<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Acute kidney injury in the perioperative period and in intensive care units (excluding renal replacement therapies)</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Carole</forename><surname>Ichai</surname></persName>
							<email>ichai@unice.fr</email>
							<affiliation key="aff1">
								<orgName type="department" key="dep1">Service de Réanimation Polyvalente</orgName>
								<orgName type="department" key="dep2">IRCAN (Inserm U1081</orgName>
								<orgName type="institution" key="instit1">CNRS UMR7284 et CHU de Nice</orgName>
								<orgName type="institution" key="instit2">Hôpital</orgName>
								<address>
									<addrLine>Pasteur 2, 30 Voie Romaine</addrLine>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="institution">CHU de Nice</orgName>
								<address>
									<postCode>06000</postCode>
									<settlement>Nice</settlement>
									<country key="FR">France</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Christophe</forename><surname>Vinsonneau</surname></persName>
							<email>christophe.vinsonneau@ch-melun.fr</email>
							<affiliation key="aff3">
								<orgName type="laboratory">Service de Réanimation</orgName>
								<orgName type="institution">Hôpital Marc Jacquet</orgName>
								<address>
									<postCode>77000</postCode>
									<settlement>Melun</settlement>
									<country key="FR">France</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Bertrand</forename><surname>Souweine</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Fabien</forename><surname>Armando</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Emmanuel</forename><surname>Canet</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Christophe</forename><surname>Clec'h</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Jean-Michel</forename><surname>Constantin</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Michaël</forename><surname>Darmon</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Jacques</forename><surname>Duranteau</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Théophille</forename><surname>Gaillot</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Arnaud</forename><surname>Garnier</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Laurent</forename><surname>Jacob</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Olivier</forename><surname>Joannes-Boyau</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Laurent</forename><surname>Juillard</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Didier</forename><surname>Journois</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Alexandre</forename><surname>Lautrette</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Laurent</forename><surname>Muller</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Matthieu</forename><surname>Legrand</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Nicolas</forename><surname>Lerolle</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Thomas</forename><surname>Rimmelé</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Eric</forename><surname>Rondeau</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Fabienne</forename><surname>Tamion</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Yannick</forename><surname>Walrave</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Lionel</forename><surname>Velly</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Jean-Michel</forename><surname>Constantin</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Joannes</forename><surname>Olivier</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Didier</forename><surname>Boyau</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Matthieu</forename><surname>Journois</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Laurent</forename><surname>Legrand</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Thomas</forename><surname>Muller</surname></persName>
						</author>
						<author>
							<persName><surname>Rimmelé</surname></persName>
						</author>
						<author>
							<persName><forename type="first">L</forename><surname>Fletcher</surname></persName>
						</author>
						<author>
							<persName><forename type="first">J</forename><surname>Velly</surname></persName>
						</author>
						<author>
							<persName><forename type="first">S</forename><surname>Amour</surname></persName>
						</author>
						<author>
							<persName><forename type="first">G</forename><surname>Ausset</surname></persName>
						</author>
						<author>
							<persName><forename type="first">V</forename><surname>Chanques</surname></persName>
						</author>
						<author>
							<persName><forename type="first">F</forename><surname>Compere</surname></persName>
						</author>
						<author>
							<persName><forename type="first">M</forename><surname>Espitalier</surname></persName>
						</author>
						<author>
							<persName><forename type="first">E</forename><surname>Garnier</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Jy</forename><surname>Gayat</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Jm</forename><surname>Lefrant</surname></persName>
						</author>
						<author>
							<persName><forename type="first">B</forename><surname>Malinovski</surname></persName>
						</author>
						<author>
							<persName><forename type="first">B</forename><forename type="middle">Tavernier</forename><surname>Rozec</surname></persName>
						</author>
						<author>
							<persName><forename type="first">L</forename><surname>Donetti</surname></persName>
						</author>
						<author>
							<persName><roleName>Tboulain</roleName><forename type="first">M</forename><surname>Alves</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Olivier</forename><forename type="middle">B</forename><surname>Rissaud</surname></persName>
						</author>
						<author>
							<persName><forename type="first">V</forename><surname>Das</surname></persName>
						</author>
						<author>
							<persName><roleName>Saint, Blanquat</roleName><forename type="first">L</forename><surname>De</surname></persName>
						</author>
						<author>
							<persName><forename type="first">M</forename><surname>Guillot</surname></persName>
						</author>
						<author>
							<persName><forename type="first">K</forename><surname>Kuteifan</surname></persName>
						</author>
						<author>
							<persName><forename type="first">C</forename><surname>Mathien</surname></persName>
						</author>
						<author>
							<persName><forename type="first">V</forename><surname>Peigne</surname></persName>
						</author>
						<author>
							<persName><forename type="first">F</forename><surname>Plouvier</surname></persName>
						</author>
						<author>
							<persName><forename type="first">D</forename><surname>Schnell</surname></persName>
						</author>
						<author>
							<persName><forename type="first">L</forename><surname>Vong</surname></persName>
						</author>
						<author>
							<persName><forename type="first">C</forename><surname>Ecoffey</surname></persName>
						</author>
						<author>
							<persName><forename type="first">F</forename><surname>Bonnet</surname></persName>
						</author>
						<author>
							<persName><forename type="first">X</forename><surname>Capdevila</surname></persName>
						</author>
						<author>
							<persName><forename type="first">H</forename><surname>Bouaziz</surname></persName>
						</author>
						<author>
							<persName><forename type="first">P</forename><surname>Albaladejo</surname></persName>
						</author>
						<author>
							<persName><forename type="first">L</forename><surname>Delaunay</surname></persName>
						</author>
						<author>
							<persName><roleName>Pansard</roleName><forename type="first">M.-L</forename><surname>Cittanova</surname></persName>
						</author>
						<author>
							<persName><forename type="first">B</forename><surname>Al Nasser</surname></persName>
						</author>
						<author>
							<persName><forename type="first">C.-M</forename><surname>Arnaud</surname></persName>
						</author>
						<author>
							<persName><forename type="first">M</forename><surname>Beaussier</surname></persName>
						</author>
						<author>
							<persName><forename type="first">M</forename><surname>Chariot</surname></persName>
						</author>
						<author>
							<persName><forename type="first">J.-M</forename><surname>Constantin</surname></persName>
						</author>
						<author>
							<persName><forename type="first">M</forename><surname>Gentili</surname></persName>
						</author>
						<author>
							<persName><forename type="first">A</forename><surname>Delbos</surname></persName>
						</author>
						<author>
							<persName><forename type="first">J.-M</forename><surname>Dumeix</surname></persName>
						</author>
						<author>
							<persName><forename type="first">J.-P</forename><surname>Estebe</surname></persName>
						</author>
						<author>
							<persName><forename type="first">O</forename><surname>Langeron</surname></persName>
						</author>
						<author>
							<persName><forename type="first">L</forename><surname>Mercadal</surname></persName>
						</author>
						<author>
							<persName><forename type="first">J</forename><surname>Ripart</surname></persName>
						</author>
						<author>
							<persName><forename type="first">M</forename><surname>Samama</surname></persName>
						</author>
						<author>
							<persName><forename type="first">J.-C</forename><surname>Sleth</surname></persName>
						</author>
						<author>
							<persName><forename type="first">B</forename><surname>Tavernier</surname></persName>
						</author>
						<author>
							<persName><forename type="first">E</forename><surname>Viel</surname></persName>
						</author>
						<author>
							<persName><forename type="first">P</forename><surname>Zetlaoui</surname></persName>
						</author>
						<author>
							<affiliation key="aff0">
								<orgName type="laboratory" key="lab1">Société française d&apos;anesthésie et de réanimation (Sfar)</orgName>
								<orgName type="laboratory" key="lab2">Société de réanimation de langue française (SRLF)</orgName>
							</affiliation>
						</author>
						<title level="a" type="main">Acute kidney injury in the perioperative period and in intensive care units (excluding renal replacement therapies)</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="MD5">0B5A04AE3EFA71DAAF111F45B09C0B7D</idno>
					<idno type="DOI">10.1186/s13613-016-0145-5</idno>
					<note type="submission">Received: 4 April 2016 Accepted: 19 April 2016</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:34+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Acute kidney injury (AKI) is a syndrome that has progressed a great deal over the last 20 years.</s><s>The decrease in urine output and the increase in classical renal biomarkers, such as blood urea nitrogen and serum creatinine, have largely been used as surrogate markers for decreased glomerular filtration rate (GFR), which defines AKI.</s><s>However, using such markers of GFR as criteria for diagnosing AKI has several limits including the difficult diagnosis of non-organic AKI, also called "functional renal insufficiency" or "pre-renal insufficiency".</s><s>This situation is characterized by an oliguria and an increase in creatininemia as a consequence of a reduction in renal blood flow related to systemic haemodynamic abnormalities.</s><s>In this situation, "renal insufficiency" seems rather inappropriate as kidney function is not impaired.</s><s>On the contrary, the kidney delivers an appropriate response aiming to recover optimal systemic physiological haemodynamic conditions.</s><s>Considering the kidney as insufficient is erroneous because this suggests that it does not work correctly, whereas the opposite is occurring, because the kidney is healthy even in a threatening situation.</s><s>With current definitions of AKI, normalization of volaemia is needed before defining AKI in order to avoid this pitfall.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Background</head><p><s>Acute kidney injury (AKI) is a syndrome that has progressed a great deal over the last 20 years.</s><s>The decrease in urine output and the increase in classical renal biomarkers, such as blood urea nitrogen (BUN) and serum creatinine (Scr), have largely been used as surrogate markers for decreased glomerular filtration rate (GFR), which defines AKI.</s><s>However, using such markers of GFR as criteria for diagnosing AKI has several limits including the difficult diagnosis of non-organic AKI, also called "functional renal insufficiency" or "pre-renal insufficiency".</s><s>This situation is characterized by an oliguria and an increase in creatininemia as a consequence of a reduction in renal blood flow (RBF) related to systemic haemodynamic abnormalities.</s><s>In this situation, "renal insufficiency" seems rather inappropriate as kidney function is not impaired.</s><s>On the contrary, the kidney delivers an appropriate response aiming to recover optimal systemic physiological haemodynamic conditions.</s><s>Considering the kidney as insufficient is erroneous because this suggests that it does not work correctly, whereas the opposite is occurring, because the kidney is healthy even in a threatening situation.</s><s>With current definitions of AKI, normalization of volaemia is needed before defining AKI in order to avoid this pitfall.</s></p><p><s>In addition, numerous data highlight that Scr has strong limitations, which make it an imperfect surrogate marker for assessing GFR and consequently AKI.</s></p><p><s>However, because its use has long been standardized around the world and it is easy and inexpensive to measure, SCr remains the dominant renal biomarker used in the current definitions of AKI.</s></p><p><s>The literal translation between related French and English terminologies can be confusing (Fig. <ref type="figure">1</ref>) 1. Acute kidney injury (AKI) is diagnosed thanks to one clinical criterium (urine output) and one biomarker for renal function (SCr).</s><s>Despite frequent situations in which renal parenchymal damage is generally present, this definition is focused on kidney "dysfunction" (in terms of the inability of the kidney to maintain homoeostasis due to a reduction in GFR).</s><s>Thus, AKI has replaced the use of the older term "acute renal failure" (ARF), which corresponds to the most severe level of AKI and is characterized by clinically relevant renal failure.</s><s>2. Acute kidney damage (AKD) refers to renal parenchymal damage that may be evidenced via histological samples or by biomarkers of renal tissue damage but not by measures of renal function.</s><s>Finally, 3. Acute kidney attack refers to situations at risk of kidney injury and kidney dysfunction.</s><s>This latter situation is frequently observed in various conditions such as in sepsis, major surgery and nephrotoxic agent administration.</s></p><p><s>These different notions of AKI and damage have emerged over the last few years, partly due to the discovery of new biomarkers for renal function that allow clinicians to accurately assess kidney damage, and consequently renal dysfunction, before any subsequent change in the classical parameters of AKI.</s></p><p><s>Clinicians must know that kidney injury is not synonymous with renal failure and that AKD and attack develop as part of the continuum of AKI.</s><s>These notions are essential since they allow clinicians to describe the conditions in which a therapeutic action might avoid or reduce the risk of worsening ARF.</s><s>Growing experimental and clinical research actively seeks to assess the role of these renal biomarkers in detecting early AKI.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Methods</head><p><s>The working method used to elaborate these recommendations is the GRADE ® method.</s><s>Following a quantitative literature analysis, this method is used to separately determine the quality of available evidence on the one hand (i.e. a confidence estimation needed to analyse the effect of the quantitative intervention) and a level of recommendation on the other.</s><s>The quality of evidence is distributed into four categories:</s></p><p><s>• High: further research is very unlikely to change the confidence in the estimate of the effect.</s></p><p><s>• Moderate: further research is likely to have an impact on the confidence in the estimate of the effect and may change the estimate of the effect itself.</s><s>• Low: further research is very likely to have an impact on the confidence in the estimate of the effect and is likely to change the estimate of the effect itself.</s><s>• Very low: any estimate of the effect is very unlikely.</s></p><p><s>The analysis of the quality of evidence is completed for every study; then, a global level of evidence is defined for a given question and criterion.</s><s>The final formulation of recommendations will always be binary, positive or negative and strong or weak.</s></p><p><s>• Strong: we recommend or we recommend not to do (GRADE 1+ ou 1−).</s><s>• Weak: we suggest or we suggest not to do (GRADE 2+ ou 2−).</s></p><p><s>The strength of the recommendations is determined according to key factors and validated by the experts after a vote, using the Delphi and GRADE Grid method.</s></p><p><s>• The estimate of the effect.</s></p><p><s>• The global level of evidence: the higher the level of evidence, the stronger the recommendation.</s><s>• The balance between desirable and undesirable effects: the more favourable the balance, the stronger the recommendation.</s><s>• Values and preferences: in case of uncertainty or large variability, the level of evidence of the recommendation is probably weak, and values and preferences must be more clearly obtained from the affected persons (patient, physician and decision-maker).</s><s>• Cost: the greater the costs or the use of resources, the weaker the recommendation.</s><s>• The elaboration of a recommendation requires that 50 % of participants should have an opinion and that &lt;20 % of participants prefer the opposite proposition.</s><s>• The elaboration of a strong recommendation requires the agreement of at least 70 % of participants.</s></p><p><s>The analysis of AKI management has been assessed according to seven themes: (1) AKI detection and diagnosis strategies; (2) AKI risk assessment; (3) non-specific AKI prevention strategies; (4) nephrotoxic agent management;</s></p><p><s>(5) pharmacological strategies for the preventive and curative treatment of AKI; (6) AKI nutritional modalities; and (7) assessment of renal function recovery after AKI.</s></p><p><s>A specific analysis was performed for AKI in paediatric patients.</s><s>A total of 24 experts were separated into nine working groups (the paediatric experts were involved in all questions).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Acute Kidney Injury</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Acute Kidney Attack</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Acute Kidney Damage</head><p><s>Fig. <ref type="figure">1</ref> Acute kidney disease: from attack to dysfunction</s></p><p><s>Publications had to have taken place after 1999 to be selected.</s><s>In case of an absence or a very low number of publications during the considered period, the timing of publications could be extended to 1990.</s></p><p><s>The level of evidence of the literature focused on AKI is globally associated with a weak level of methodology.</s><s>The experts were, therefore, faced with three situations:</s></p><p><s>• For some questions, in the existence of several trials or meta-analyses with an acceptable methodological quality, the GRADE ® method was totally applicable and allowed recommendations.</s><s>• When no meta-analysis was available to answer the question, a qualitative analysis by the experts following the GRADE ® method was possible and a systematic review was performed.</s><s>• For some questions, in the absence of recent studies, no recommendation was possible.</s></p><p><s>After a synthesis of the experts, work and, implementation of the GRADE ® method, 33 recommendations were formally developed by the organizing committee.</s><s>Among all recommendations, 9 were strong (Grade 1±) and 16 were weak (Grade 2±), and for eight questions, it was impossible to apply the GRADE ® method.</s></p><p><s>All of these recommendations were submitted to a reviewing group for a Delphi method assessment.</s><s>After two rounds of voting and evaluation and after various amendments, a strong agreement was reached for 32 (99 %) recommendations.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="1.">How to establish the diagnosis of AKI and its severity</head><p><s>R1.3-To estimate GFR, we do not recommend the use of formulas (Cockroft-Gault, MDRD, CKD-EPI) in critically ill patients or in the post-operative period.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>(Grade 1−) STRONG Agreement</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Table 1 Classification of AKI according to the KDIGO criteria [1]</head><p><s>The stage is determined by the worse of either the "serum creatinine" or "urine output" criteria</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Stage Serum creatinine</head><p><s>Urine output 1 ≥26.5 μmol/l or 1.5-1.9</s><s>times baseline serum creatinine level &lt;0.</s><s><ref type="bibr" target="#b0">[1]</ref>.</s><s>As of 2015, there are no recent studies questioning this definition, and most of the available scientific trials that have focused on AKI and ARF use the KDIGO definition.</s><s>AKI is defined by an increase in Scr which indicates a reduction in GFR.</s><s>The best way to evaluate GFR is given by the calculated creatinine clearance using the formula UV/P (ml/min) (U being the urinary creatinine concentration in µmol/l, V the urinary volume expressed in ml per unit time, P the Scr concentration in µmol/l).</s><s>This technique requires the collection of at least 1 h worth of urine ("flash creatinine clearance") <ref type="bibr" target="#b1">[2]</ref>.</s><s>Estimated creatinine clearance formulas (sMDRD, CKD-EPI, Cockroft and Gault) must not be used because they were developed for stable patients with chronic renal insufficiency (CRI), but not validated in critically ill patients <ref type="bibr" target="#b1">[2]</ref>.</s><s>However, it is possible to use them carefully during pre-operative visits for surgical patients.</s><s>An accurate assessment of GFR is essential for adapting the dosing of drugs, which are eliminated by kidney.</s></p><p><s>The KDIGO classification represents an optimized synthesis of both pre-existing classifications (RIFLE and AKIN), which were previously elaborated by an international expert group including nephrologists and intensivists aiming to characterize the severity of AKI <ref type="bibr" target="#b0">[1,</ref><ref type="bibr" target="#b2">3]</ref>.</s><s>Since the publication of the RIFLE <ref type="bibr" target="#b3">[4]</ref> and AKIN <ref type="bibr" target="#b4">[5]</ref> classifications, a wide literature highlights that they are well correlated with AKI severity because the resulting morbidity (risk of requiring renal replacement therapy <ref type="bibr" target="#b5">[6]</ref><ref type="bibr" target="#b6">[7]</ref><ref type="bibr" target="#b7">[8]</ref><ref type="bibr" target="#b8">[9]</ref>, in-ICU and in-hospital lengths of stay, risk of CRI development <ref type="bibr" target="#b9">[10]</ref> and mortality rate increase proportionally with the stage of severity of these classifications <ref type="bibr" target="#b5">[6]</ref><ref type="bibr" target="#b6">[7]</ref><ref type="bibr" target="#b7">[8]</ref><ref type="bibr" target="#b8">[9]</ref>.</s><s>Following AKI diagnosis, the determination of its severity is required for evaluating prognosis.</s><s>paediatric formula <ref type="bibr" target="#b11">[12]</ref> and is compared to the reference value of 100 ml/min/1.73</s><s>m 2 if the previous value of the patient is unknown, which is frequent in this population.</s><s>This pRIFLE classification has been subsequently validated in various prospective studies considering children in ICUs or those in the early post-operative period after cardiac surgery <ref type="bibr" target="#b12">[13]</ref>.</s><s>By extension, the severity of AKI is also based on the pRI-FLE (Table <ref type="table">2</ref>).</s><s>based on an estimated Scr clearance and urine output has been proposed by Akcan-Arikan et al. <ref type="bibr" target="#b10">[11]</ref>.</s><s>In these modified criteria, AKI is defined by the presence of at least one of the following:</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Table 2 Diagnosis and severity criteria of AKI in paediatric patients</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Grade</head><p><s>• a decrease in the estimated creatinine clearance &gt;25 % • a urine output &lt;0.5 ml/kg/h for 8 h</s></p><p><s>In this classification, the estimated creatinine clearance is calculated according to the Schwartz's</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.">Strategies for the early diagnosis of AKI</head><p><s>R2.1-We recommend not to use renal biomarkers to diagnose early AKI.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>(Grade 1−) WEAK agreement</head><p><s>Rationale: As mentioned in the introduction, regardless of its severity, AKI is characterized by renal dysfunction expressed by an increased Scr concentration or a decrease in urine output.</s><s>When considering pathophysiology, this phase is always preceded by kidney attacks (of mostly haemodynamic or inflammatory nature), which can lead to irreversible parenchymal kidney damage and finally renal dysfunction when repeated <ref type="bibr" target="#b13">[14,</ref><ref type="bibr" target="#b14">15]</ref>.</s><s>Currently, no curative strategies enable clinicians to treat such established damage, and AKI is clearly associated with an increased independent risk of in-hospital mortality and CRI within a few years following AKI <ref type="bibr" target="#b15">[16]</ref><ref type="bibr" target="#b16">[17]</ref><ref type="bibr" target="#b17">[18]</ref><ref type="bibr" target="#b18">[19]</ref><ref type="bibr" target="#b19">[20]</ref><ref type="bibr" target="#b20">[21]</ref>.</s><s>Therefore, current data strongly suggest the need to research risk factors for AKI and to detect early kidney attack episodes <ref type="bibr" target="#b0">[1,</ref><ref type="bibr" target="#b21">[22]</ref><ref type="bibr" target="#b22">[23]</ref><ref type="bibr" target="#b23">[24]</ref>.</s><s>Consequently, over the last 10 years multiple renal biomarkers capable of detecting early acute kidney attacks have been developed.</s><s>These biomarkers are essentially proteins synthesized subsequent to renal damage.</s></p><p><s>Numerous studies have evaluated the relevance of plasma and urinary renal biomarkers for diagnosing early AKI <ref type="bibr" target="#b0">[1,</ref><ref type="bibr" target="#b24">25,</ref><ref type="bibr" target="#b25">26]</ref>.</s><s>This evaluation, which is still ongoing for several of them, reports sensitivity ranging from 70 to 92 % and specificity from 70 to 95 %, depending on the nature of the biomarker, the sample type (plasma or urine) and, above all, the threshold level used to define AKI.</s><s>Cystatin appears to be a biomarker for GFR and consequently an earlier and more efficient functional marker than Scr.</s><s>A recent metaanalysis including 19 studies and 3336 patients reports that plasma cystatin has a sensitivity of 71 % and a specificity of 92 %, a predictive value which is higher than that of urinary cystatin and Scr <ref type="bibr" target="#b26">[27]</ref>.</s><s>Renal tubular biomarkers indicate kidney tissue damage.</s><s>Among them, the most evaluated are kidney injury molecule-1 (KIM-1), neutrophil gelatinase-associated lipocalin (NGAL), lipid acid-binding protein (L-FABP), interleukin-18 (IL-18), β2-microglobulin and cell cycle arrest biomarkers [insulin growth factor-binding protein 7 (IGFBP 7) and tissue inhibitor of metalloproteinase-2 (TIMP-2)].</s><s>A recent meta-analysis including 23 studies and 4512 patients showed a moderate sensitivity and specificity for IL-18 measurements <ref type="bibr" target="#b27">[28]</ref>.</s><s>KIM-1, which has also been evaluated in a recent meta-analysis, seems to be an accurate biomarker for the diagnosis of early risk of AKI <ref type="bibr" target="#b28">[29]</ref>.</s><s>As found in a meta-analysis performed in 2009, urinary and plasma NGAL determination seems to be useful for the early diagnosis of AKI <ref type="bibr" target="#b29">[30]</ref>.</s><s>This study also demonstrated that NGAL has a good predictive value with reference to mortality rates and renal replacement requirements (RRTs) during ICU hospitalization.</s><s>Similar to data related to other biomarkers, this meta-analysis confirms that NGAL measurements can be viewed as an accurate method for facilitating the early detection of kidney damage while no real benefit has been shown for the diagnosis of renal dysfunction.</s><s>Recently, the same authors have reported similar results based on several prospective observational studies, leading to a cohort of 2322 critically ill patients <ref type="bibr" target="#b30">[31]</ref>.</s><s>However, results issued from this latter meta-analysis show a high heterogeneity between studies related to various conditions, abnormal cut-off values and measurement timings.</s><s>Both IGFBP 7 and TIMP-2 biomarkers for cell cycle arrest have been assessed and compared with other major renal biomarkers in 738 critically ill patients at risk of AKI <ref type="bibr" target="#b31">[32]</ref>.</s><s>Results show that, in patients with various pathologies, a combined IGFBP7 and TIMP-2 measurement results in a higher sensitivity and specificity as compared with all other studied biomarkers (AUC = 0.8).</s><s>Moreover, the risks of death and of RRT increase with high levels of these two biomarkers.</s><s>A recent study with a cohort of 420 patients has confirmed that this biological tool is relevant for detecting and diagnosing early renal damage <ref type="bibr" target="#b32">[33]</ref>.</s></p><p><s>While data largely support that these biomarkers are useful for assessing early kidney damage and severity, the performance of these biomarkers and their daily use raise several problems.</s><s>These various biomarkers indicate different mechanisms of injury: ischaemia, hypoxia, cellular regeneration or cell cycle arrest.</s><s>Their syntheses are located in different sites, and they are activated with different kinetics following kidney injury <ref type="bibr" target="#b22">[23,</ref><ref type="bibr" target="#b25">26,</ref><ref type="bibr" target="#b33">34]</ref>.</s><s>Despite a growing literature, there is no study that truly demonstrates their utility in clinical practice for critically ill patients at risk of AKI.</s><s>Several reasons preclude the implementation of such tools in current practice: multiple biomarkers, no real specificity, various kinetics of synthesis, impact of the pre-existing renal dysfunction, impact of the causal pathway leading to AKI and high costs.</s><s>Therefore, until now, there is no ideal renal biomarker and the future use of these tools points towards combined and repeated measurements within time (kinetics).</s><s>Finally, there are no data demonstrating the utility of such measurements for diagnosing AKI with dysfunction, which is simply based on Scr modifications or urine output, or for its therapeutic management.</s></p><p><s>In summary, there is at this time no randomized controlled study allowing experts to recommend the measurement of one or several renal biomarkers in order to diagnose AKI, which is already associated with renal dysfunction.</s><s>On the other hand, the literature gives a strong signal that these biomarkers are useful tools that facilitate the early diagnosis of AKD, a stage which increases both the risks of AKI and death in critically ill patients.</s><s>In the light of the current context, the generalization of such measurements remains difficult, especially as concerns the need to choose one or several biomarkers, the clinical relevance, significance thresholds and the timing for measurement(s), all of which are parameters that require more knowledge according to the type of patients.</s></p><p><s>Rationale for paediatric patients: It is not possible to directly extrapolate results issued from studies performed on adults to paediatric patients.</s><s>Indeed, multiple parameters such as aetiology or treatment of AKI, presence of comorbidities and anthropometric characteristics are strongly different between paediatric and adult patients <ref type="bibr" target="#b34">[35]</ref>.</s><s>However, prospective trials performed in paediatric populations, especially in the post-operative cardiac surgery period, suggest that urinary renal biomarkers could be useful for the early diagnosis of AKI <ref type="bibr" target="#b35">[36]</ref>.</s><s>Moreover, data issued from a prospective study in critically ill paediatric patients have shown that estimated GFRs based on cystatin C levels have a higher sensitivity than those based on the usual equations using Scr <ref type="bibr" target="#b36">[37]</ref>.</s></p><p><s>these preliminary studies show a poor level of proof.</s><s>Both the significance of resistive index variation and doubts related to the reproduction of measurements are major limitations for the interpretation of these results as well as for their recommendation in daily practical clinical use.</s></p><p><s>The second renal Doppler ultrasound research trend is focused on the assessment of renal prognosis.</s><s>An observational study including 37 patients in septic shock suggests that the resistive index might help predict the occurrence of AKI on day 5 <ref type="bibr" target="#b43">[44]</ref>.</s><s>Several other preliminary trials also suggest that the resistive index would allow clinicians to distinguish pre-renal (non-organic) from intrarenal (organic) AKI <ref type="bibr" target="#b44">[45]</ref><ref type="bibr" target="#b45">[46]</ref><ref type="bibr" target="#b46">[47]</ref>, to predict renal function outcome at days 3 or 5 <ref type="bibr" target="#b42">[43,</ref><ref type="bibr" target="#b47">[48]</ref><ref type="bibr" target="#b48">[49]</ref><ref type="bibr" target="#b49">[50]</ref> and to predict RRT <ref type="bibr" target="#b50">[51]</ref>.</s><s>Thus, these studies suggest that the resistive index could be a tool for assessing renal prognosis with a good sensitivity and specificity <ref type="bibr" target="#b44">[45,</ref><ref type="bibr" target="#b46">[47]</ref><ref type="bibr" target="#b47">[48]</ref><ref type="bibr" target="#b48">[49]</ref><ref type="bibr" target="#b49">[50]</ref><ref type="bibr" target="#b50">[51]</ref>.</s><s>Certain studies performed on non-critically ill septic patients  have small sample sizes, which are mostly monocentric in nature or have poor methodological design <ref type="bibr">[45-47, 49, 50]</ref>.</s><s>A recent study including 94 patients reported contradictory results and suggested that the resistive index had a limited performance when used to evaluate renal prognosis <ref type="bibr" target="#b51">[52]</ref>.</s><s>This contradictory set of results could be explained by two limitations associated with this technique.</s><s>The first is the significance of the resistive index values and variations, which remains unclear because the relationship between this parameter and renal vascular resistances seems to be poor, perhaps due to a large number of additional factors implicated in AKI <ref type="bibr" target="#b37">[38,</ref><ref type="bibr" target="#b38">39,</ref><ref type="bibr" target="#b52">[53]</ref><ref type="bibr" target="#b53">[54]</ref><ref type="bibr" target="#b54">[55]</ref><ref type="bibr" target="#b55">[56]</ref>. Indeed, experiments performed on models of ex vivo kidneys have confirmed a major role for vascular compliance (modification in vascular diameter following changes in pressure) or pulse pressure as a determinant of the resistive index <ref type="bibr" target="#b53">[54]</ref><ref type="bibr" target="#b54">[55]</ref><ref type="bibr" target="#b55">[56]</ref>.</s><s>These experimental data have been recently confirmed in kidney-transplanted patients <ref type="bibr" target="#b56">[57]</ref>.</s><s>The second limitation is the feasibility and reproducibility of measures: a recent study confirms the feasibility of resistive index measurement after a short session of education for inexperienced intensivists, but the reproducibility between experienced and inexperienced ones is poor with variations in the resistive index reaching ±0.1 <ref type="bibr" target="#b49">[50]</ref>.</s><s>Taking into account the available data, this promising technique deserves to be further evaluated and cannot be recommended for current use.</s><s>Rationale: Measurement of renal velocity by Doppler ultrasound is a non-invasive and rapid surrogate method that allows the instantaneous assessment of parenchymal renal perfusion <ref type="bibr" target="#b37">[38,</ref><ref type="bibr" target="#b38">39]</ref>.</s><s>Because of its easily accurate and repeatable measurements, this approach supposedly allows the assessment of modifications of RBF in response to therapeutic management.</s><s>Therefore, the past 10 years have seen considerable growth in research on critically ill patients in order to evaluate the performance of Doppler ultrasound during AKI.</s><s>Research has been developed in two ways.</s></p><p><s>The first research trend is focused on the use of the resistive index as a tool for measuring intrarenal haemodynamics.</s><s>A recent experimental study reported that measuring RBF was impossible using Doppler sonography.</s><s>Indeed, there was no relationship between measured RBF and estimated RBF by sonographic Doppler and the time for ultrasonographic transit, which was previously validated for regional blood flow measurements <ref type="bibr" target="#b39">[40]</ref>.</s><s>The same study highlighted that the interpretation of variations in the resistive index is difficult due to a very low relationship between variations in RBF after various therapeutic manoeuvres and variations in resistive index <ref type="bibr" target="#b39">[40]</ref>.</s><s>The most predictive parameter of 20 % variation in RBF issued from the Doppler was the variation in diastolic velocity, but the AUC was poor (0.75) <ref type="bibr" target="#b39">[40]</ref>.</s><s>Several authors have assessed resistive index variation in response to increasing doses of noradrenaline or "renal low" dose dopamine.</s><s>Results suggest that the resistive index might be a guided goal measurement allowing the optimization of catecholamine doses in order to potentially improve renal perfusion <ref type="bibr" target="#b40">[41,</ref><ref type="bibr" target="#b41">42]</ref>.</s><s>Finally, a further study did not find any variation in the resistive index following an intravascular load, regardless of pre-existing renal function and the response to this load as assessed by a variation in the systolic ejection volume <ref type="bibr" target="#b42">[43]</ref>.</s><s>Despite promising results,</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.">How to assess the risk of AKI</head><p><s>after non-cardiac major surgery.</s><s>This score is based on the attribution of points for each of the nine risk factors as follows: age ≥56 years, male sex, congestive cardiac insufficiency, ascites, arterial hypertension, emergency surgeries, intraperitoneal surgery, CRI (pre-operative Scr ≥1.2 mg/dl) and diabetes (oral or insulin treatments).</s><s>The ROC curve associated with this score was 0.80 ± 0.02.</s><s>The incidence of AKI increased from 0.2 % in patients with 0-2 risk factors to 9.5 % in those with more than five risk factors, and this incidence increased with the number of risk factors.</s></p><p><s>Table <ref type="table" target="#tab_4">4</ref> summarizes the major nephrotoxic agents that are most frequently used in ICUs and during the perioperative period <ref type="bibr" target="#b59">[60,</ref><ref type="bibr" target="#b60">61]</ref>.</s><s>Among them, some could be replaced by non-nephrotoxic agents or administered using associated preventive measures (see the corresponding chapters).</s></p><p><s>The identification of patient exposure to nephrotoxic agents/procedures is essential for correctly adjusting patient monitoring and management.</s><s>In high-risk situations, the close monitoring of urine output and Scr in ICUs would help assess the evolution of renal function and the efficiency of strategies for preventing AKI (see corresponding chapters).</s><s>If AKI occurs, the same type of measures will continue in order to limit a worsening of function and avoiding the further compromise of renal recovery.</s><s>R3.1-We recommend looking for risk factors for AKI related to the patient's susceptibilities and/or to exposures (Table <ref type="table" target="#tab_3">3</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>(Experts opinion) STRONG Agreement</head><p><s>Rationale: In hospitalized patients, all the different predictive scores for AKI reported in the literature describe more or less the same risk factors, which are related to patient susceptibilities and exposures.</s><s>However, the weight of each of risk factors differs according to the type of patient and the surrounding procedures.</s></p><p><s>The greater the number of risk factors, the greater the risk of AKI.</s><s>The two most important risk factors related to patient susceptibilities are age and pre-existing chronic kidney disease.</s><s>The age threshold above which the risk is present varies in the literature, from 55 to 65 years old, according to the context.</s><s>Among procedure-related risk factors, the most frequently found are sepsis and surgery, or even better the perioperative period <ref type="bibr" target="#b14">[15,</ref><ref type="bibr" target="#b57">58,</ref><ref type="bibr" target="#b58">59]</ref>.</s><s>The aim of this chapter is neither to supply an exhaustive review of these predictive scores <ref type="bibr" target="#b14">[15]</ref>, nor to create a global score for all patients and all procedures.</s><s>For example, it has been shown that prolonged extracorporeal circulation (over 2 h) is a major risk factor for AKI during cardiac surgery.</s><s>Kheterpal et al. <ref type="bibr" target="#b58">[59]</ref> defined a score ("AKI Risk Index") designed to predict the development of AKI R3.2-In high-risk situations, we suggest monitoring urine output and Scr to detect the development of AKI and apply the appropriate preventive measures.</s></p><p><s>(Experts opinion) STRONG agreement</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="4.">Strategies for the non-specific prevention of AKI</head><p><s>was 331 ml (1709 ± 1164 vs 1379 ± 886 ml, p = 0.02).</s><s>However, in this latter study, fluid balance was similar between both groups on day 4 (56.6 vs 55.8 ml/kg).</s><s>On 11 October 11 2013, the European Agency for Medicines (EMA) made public its conclusions concerning the administration of HES <ref type="bibr" target="#b74">[75]</ref>: HES must not be used in septic, critically ill or burned patients.</s><s>Their administration remains possible in case of haemorrhage shock when crystalloids are not sufficient (for a period not exceeding 24 h, and in association with renal function monitoring for 90 days).</s></p><p><s>R4.1-We recommend not administering hydroxyethyl starch (HES) in the ICU.</s></p><p><s>(Grade 1−) STRONG agreement R4.2-We suggest the preferential use of crystalloids instead of colloids for fluid loading.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>(Grade 2+) STRONG agreement</head><p><s>Rationale: Several randomized or observational studies and meta-analyses have examined the beneficial effect of a preferential administration of colloids compared to crystalloids <ref type="bibr" target="#b61">[62]</ref><ref type="bibr" target="#b62">[63]</ref><ref type="bibr" target="#b63">[64]</ref><ref type="bibr" target="#b64">[65]</ref><ref type="bibr" target="#b65">[66]</ref><ref type="bibr" target="#b66">[67]</ref><ref type="bibr" target="#b67">[68]</ref><ref type="bibr" target="#b68">[69]</ref><ref type="bibr" target="#b69">[70]</ref><ref type="bibr" target="#b70">[71]</ref><ref type="bibr" target="#b71">[72]</ref><ref type="bibr" target="#b72">[73]</ref>.</s><s>In the ICU, the use of HES, regardless of its type, has been reported to be associated with an increase in mortality rate, AKI incidence and the need for RRT in several meta-analyses with a high level of proof <ref type="bibr" target="#b57">[58]</ref><ref type="bibr" target="#b58">[59]</ref><ref type="bibr" target="#b59">[60]</ref><ref type="bibr" target="#b60">[61]</ref><ref type="bibr" target="#b61">[62]</ref><ref type="bibr" target="#b62">[63]</ref><ref type="bibr" target="#b63">[64]</ref><ref type="bibr" target="#b64">[65]</ref><ref type="bibr" target="#b65">[66]</ref><ref type="bibr" target="#b66">[67]</ref><ref type="bibr" target="#b67">[68]</ref><ref type="bibr" target="#b68">[69]</ref><ref type="bibr" target="#b69">[70]</ref><ref type="bibr" target="#b70">[71]</ref><ref type="bibr" target="#b72">73]</ref>.</s><s>A Cochrane meta-analysis simultaneously considering all colloids did not find any beneficial effect associated with the preferential use of colloids, regardless of nature, compared with crystalloids.</s><s>The same study reported an increased risk of death related to HES administration <ref type="bibr" target="#b71">[72]</ref>.</s><s>Only one recent randomized controlled study suggested a decrease in 90-day mortality (secondary endpoint) associated with fluid vascular loading performed with colloids, the absence of deleterious effects in terms of 28-day outcomes (primary endpoint) and the absence of a higher risk of AKI (secondary endpoint) <ref type="bibr" target="#b14">[15]</ref>.</s><s>However, in this study, judgement criteria in favour of colloids were secondary in nature and the weakness of the benefit led the authors to consider their results as investigational only <ref type="bibr" target="#b14">[15]</ref>.</s><s>Therefore, these results cannot justify preferential use.</s></p><p><s>A recent meta-analysis performed during the perioperative period, including several studies with low levels of proof, did not find any effect of fluid solution on AKI occurrence <ref type="bibr" target="#b73">[74]</ref>.</s><s>The low prevalence of AKI in this population and thus the low power of studies considered in this meta-analysis make it difficult to interpret this result <ref type="bibr" target="#b73">[74]</ref>.</s></p><p><s>In terms of fluid and sodium balance or haemodynamic stability, the benefit of colloids seems limited.</s><s>Indeed, in two trials with a high level of proof for assessing efficiency of fluid balance and vascular load, a limited difference in favour of HES was found.</s><s>In Myburgh's et al. trial <ref type="bibr" target="#b62">[63]</ref>, the difference in terms of fluid balance on day 4 corresponded to 61 ml (982 ± 1069 vs 921 ± 1161, p = 0.03).</s><s>Guidet et al. <ref type="bibr" target="#b66">[67]</ref> found that the difference in fluid vascular load R4.3-We suggest preferring balanced solutions in case of large fluid vascular loading.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>(Grade 2+) STRONG agreement</head><p><s>Rationale: At this time, there are no randomized studies demonstrating any beneficial effect in terms of mortality when solutions with a low chloride concentration are preferentially administered in critically ill patients or in the perioperative period.</s><s>However, experimental data show that hyperchloraemia may cause renal vasoconstriction in a manner proportional to severity <ref type="bibr" target="#b75">[76]</ref><ref type="bibr" target="#b76">[77]</ref><ref type="bibr" target="#b77">[78]</ref>.</s><s>One clinical trial has found that an infusion of 2 l of 0.9 % saline is associated with a decrease in cortical renal perfusion (assessed by magnetic resonance imaging) as compared with an infusion of balanced solutions in healthy volunteers <ref type="bibr" target="#b78">[79]</ref>.</s><s>All data issued from observational cohort studies with or without propensity scores and matching on large samples highlight the deleterious effects of non-balanced solutions, especially on the kidney <ref type="bibr" target="#b79">[80,</ref><ref type="bibr" target="#b80">81]</ref>.</s><s>Three recent, large, observational trials show that volume loading with 0.9 % NaCl is associated with increased morbidity, especially for kidney dysfunction, as compared with volume loading using balanced solutions <ref type="bibr" target="#b81">[82]</ref><ref type="bibr" target="#b82">[83]</ref><ref type="bibr" target="#b83">[84]</ref>.</s><s>In an observational study including 30,994 patients with abdominal surgery, Shaw et al. <ref type="bibr" target="#b81">[82]</ref> found that patients receiving 0.9 % NaCl compared to those receiving balanced solutions had a higher rate of post-operative complications and RRT (4.8 vs 1 %, p &lt; 0.05).</s><s>Similar results have been found in the sequential observational study performed by Yunos et al. <ref type="bibr" target="#b82">[83]</ref> in critically ill patients.</s><s>In a cohort of 5000 surgical patients matched with a propensity score, McCluskey et al. <ref type="bibr" target="#b83">[84]</ref> also found that hyperchloraemia was an independent risk factor for post-operative AKI.</s><s>However, there is currently no real randomized controlled trial that confirms these data and results concerning mortality remain uncertain <ref type="bibr" target="#b81">[82,</ref><ref type="bibr" target="#b84">85]</ref>.</s><s>A recent meta-analysis including more than 6000 patients concluded that the use of crystalloids rich in chloride increases the risk of AKI and blood transfusion, without affecting mortality rates as compared with balanced solutions <ref type="bibr" target="#b85">[86]</ref>.</s><s>Finally, considering these data, we consider non-balanced solutions as potentially deleterious, especially for kidneys, and suggest minimizing their use, especially for large-volume resuscitation <ref type="bibr" target="#b86">[87]</ref>.</s></p><p><s>to allow a MAP of 75-85 mmHg in patients suffering from persistent renal dysfunction despite an appropriate fluid load and a MAP of 65 mmHg.</s></p><p><s>In an observational study including 33,300 patients with non-cardiac surgery, a MAP &lt;55-60 mmHg was associated with an increase in post-operative AKI <ref type="bibr" target="#b98">[99]</ref>.</s><s>In cardiac surgery, a MAP under 50 mmHg was associated with an increased rate of post-operative AKI, whereas a MAP of 60-70 mmHg was a protective factor <ref type="bibr" target="#b99">[100]</ref>.</s><s>In the same context, a 26-mmHg decrease in MAP was associated with a higher rate of AKI after cardiac surgery <ref type="bibr" target="#b100">[101]</ref>.</s></p><p><s>R4.4-We recommend maintaining a minimal level of mean arterial pressure (MAP) between 60 and 70 mmHg to prevent and treat AKI.</s></p><p><s>(Grade 1+) STRONG agreement R4.5-We suggest considering that patients with chronic arterial hypertension require a MAP target &gt;70 mmHg.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>(Grade 2+) STRONG agreement</head><p><s>Rationale: The optimal level of MAP during AKI has been rarely assessed.</s><s>Because a MAP level of 65 mmHg is a survival factor in critically ill patients <ref type="bibr" target="#b87">[88]</ref>, especially during sepsis <ref type="bibr" target="#b88">[89]</ref><ref type="bibr" target="#b89">[90]</ref><ref type="bibr" target="#b90">[91]</ref>, this value is usually considered as the lowest acceptable level required for maintaining renal perfusion during AKI <ref type="bibr" target="#b91">[92]</ref>.</s><s>A diastolic arterial pressure &lt;50-55 mmHg is associated with an increased AKI occurrence during septic shock <ref type="bibr" target="#b92">[93,</ref><ref type="bibr" target="#b93">94]</ref>.</s><s>Because the threshold for renal autoregulation may be higher in the elderly and patients with a cardiovascular history, the requirement of maintaining MAP above a 65-mmHg threshold is frequently questioned for these patients.</s><s>In terms of mortality, a recent multicentre randomized trial showed that a level of 80-85 mmHg had no beneficial effect compared with a level of 65-70 mmHg <ref type="bibr" target="#b94">[95]</ref>.</s><s>Two observational studies with a short follow-up (24 h) found no benefit for kidney function between a MAP of 65 versus 85 mmHg <ref type="bibr" target="#b95">[96,</ref><ref type="bibr" target="#b96">97]</ref>.</s><s>However, several studies suggest that a MAP above 65 mmHg may be beneficial for the management of AKI <ref type="bibr" target="#b91">[92,</ref><ref type="bibr" target="#b94">95,</ref><ref type="bibr" target="#b97">98]</ref>.</s><s>In a randomized trial performed with 776 patients with septic shock, a MAP level of 80-85 mmHg (vs 65-70 mmHg) was associated with a decrease in the risk of RRT in patients with chronic arterial hypertension, while mortality rates were similar in both groups <ref type="bibr" target="#b94">[95]</ref>.</s><s>During AKI, a retrospective study with a cohort of 274 patients with sepsis suggested that a MAP &lt;75 mmHg predicts the need for RRT <ref type="bibr" target="#b97">[98]</ref>.</s><s>In a retrospective trial including 423 patients, a level of MAP &lt;75 mmHg was associated with an increase in AKI severity during septic shock <ref type="bibr" target="#b91">[92]</ref>.</s><s>These data underline the need to personalize the MAP threshold for each patient and</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Grade 2+) STRONG agreement</head><p><s>Rationale: In the perioperative period, regardless of the type of surgery, intraoperative haemodynamic optimization aiming at a cardiac index threshold of 4.5 l/min/m 2 , an oxygen delivery of 600 ml/min/m 2 or an oxygen consumption of 170 ml/min/m 2 allows clinicians to limit hypovolaemic episodes and consequently reduces the risk of post-operative AKI <ref type="bibr" target="#b101">[102,</ref><ref type="bibr" target="#b102">103]</ref>.</s><s>These goals can be reached using a pulmonary arterial catheter, oesophageal Doppler or devices using arterial pulse contour analysis.</s><s>The means include vascular fluid loading, vasopressor agents and inotropic drugs.</s><s>Similar recommendations can be made in ICUs, but the level of proof is low.</s></p><p><s>In the ICU, fluid overload is associated with an increased incidence in AKI and its severity, regardless of the need for RRT <ref type="bibr" target="#b20">[21,</ref><ref type="bibr" target="#b103">[104]</ref><ref type="bibr" target="#b104">[105]</ref><ref type="bibr" target="#b105">[106]</ref><ref type="bibr" target="#b106">[107]</ref><ref type="bibr" target="#b107">[108]</ref>.</s><s>An increase in weight above 10 % is the most frequently studied parameter.</s><s>All studies concerning this point are purely observational; comparative studies do not currently exist.</s><s>Despite the relationship between fluid overload and AKI frequency and severity, there are no data, demonstrating that the control of fluid overload may have a beneficial renal effect.</s><s>In other words, it has not been demonstrated that fluid overload is the cause or the consequence of AKI.</s><s>Such fluid overload can be a simple marker of severity and not the cause of AKI.</s><s>In the perioperative period, the control of fluid balance limits post-operative complications.</s><s>During AKI, no benefit of controlling fluid balance has been demonstrated for kidney function <ref type="bibr" target="#b108">[109,</ref><ref type="bibr" target="#b109">110]</ref>.</s><s>in those with risk factors (chronic kidney disease, diabetes, concomitant administration of nephrotoxic agents) <ref type="bibr" target="#b120">[121]</ref>.</s><s>In the ICU, according to the definition used, this incidence varies from 16 to 31 % <ref type="bibr" target="#b121">[122]</ref><ref type="bibr" target="#b122">[123]</ref><ref type="bibr" target="#b123">[124]</ref><ref type="bibr" target="#b124">[125]</ref>. Several other risk factors for kidney injury are usually concomitantly found in critically ill patients (hypotension, sepsis, nephrotoxic drugs), making it difficult to consider contrast media directly and solely responsible for AKI.</s><s>Thus, most studies evaluate post-operative cardiac surgery patients or cardiology patients, but there are few trials available in critically ill patients.</s></p><p><s>The available studies considered in a large number of meta-analyses, which are unfortunately heterogeneous and for the most part poorly conducted (especially as concerns older studies), lead to conflicting results <ref type="bibr" target="#b125">[126]</ref><ref type="bibr" target="#b126">[127]</ref><ref type="bibr" target="#b127">[128]</ref><ref type="bibr" target="#b128">[129]</ref><ref type="bibr" target="#b129">[130]</ref><ref type="bibr" target="#b130">[131]</ref>.</s><s>Moreover, in more recent metaanalyses positive results favouring NAC are demonstrated only when they include published trials.</s><s>When considering all studies, especially unpublished ones, this favourable result disappears <ref type="bibr" target="#b127">[128,</ref><ref type="bibr" target="#b131">132]</ref>.</s><s>Alkalinization with sodium bicarbonate has been proposed for the prevention of CIN.</s><s>Two recent meta-analyses have found a beneficial effect associated with sodium bicarbonate in terms of a decrease in AKI incidence, whereas there was no effect on the need for RRT and in-hospital mortality <ref type="bibr" target="#b129">[130,</ref><ref type="bibr" target="#b132">133]</ref>.</s><s>Two recent prospective randomized trials did not confirm these later results.</s><s>The first one demonstrated that hydration with 0.9 % saline was associated with a lower decrease in GFR and a lower incidence of CIN as compared with sodium bicarbonate (1 vs 9 %, p = 0.02) <ref type="bibr" target="#b133">[134]</ref>.</s><s>In the second study, the results found that there was no difference in the incidence of CIN between 0.9 % saline and sodium bicarbonate (3 vs 5.1 %, p = 0.23) <ref type="bibr" target="#b134">[135]</ref>.</s><s>Currently, though sodium bicarbonate may be a satisfactory alternative to 0.9 % saline, there is still no proof of any advantage associated with such a preventive strategy.</s><s>Other drugs that have been assessed have never shown any undisputable positive effect and cannot be recommended <ref type="bibr" target="#b135">[136,</ref><ref type="bibr" target="#b136">137]</ref>.</s><s>Finally, fluid vascular loading seems to be the most efficient prophylactic management <ref type="bibr" target="#b137">[138,</ref><ref type="bibr" target="#b138">139]</ref>.</s><s>Such a strategy minimizes risk exposure when considering that a limited volume of fluids is needed in this indication (about 1000 to 1500 ml within several hours) and will not have deleterious consequences, except for patients with cardiac insufficiency or fluid overload.</s><s>Moreover, the expected benefit in terms of decreased incidence of AKI following the procedure should maintain sufficient urine output to allow rapid body water elimination.</s><s>R4.9-We suggest using noradrenaline as a first-line treatment for maintaining MAP goals if a vasopressor drug is required.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>(Grade 2+) STRONG agreement</head><p><s>Rationale: The use of vasopressors during AKI to reach or maintain the previously mentioned MAP and DAP goals is logical when fluid vascular load does not allow clinicians to reach them.</s><s>Several observational studies show that noradrenaline is the vasoconstrictive agent of choice, which combines the best compromise in term of cost, safety and ease of use <ref type="bibr" target="#b110">[111]</ref><ref type="bibr" target="#b111">[112]</ref><ref type="bibr" target="#b112">[113]</ref><ref type="bibr" target="#b113">[114]</ref><ref type="bibr" target="#b114">[115]</ref><ref type="bibr" target="#b115">[116]</ref><ref type="bibr" target="#b116">[117]</ref>.</s><s>There is no controlled study concerning this specific point.</s><s>Terlipressin may be an alternative to noradrenaline in the absence of coronary artery disease <ref type="bibr" target="#b117">[118,</ref><ref type="bibr" target="#b118">119]</ref>.</s><s>Vasopressin has been used in rare cases, but the low sample size of these studies does not allow particular recommendations.</s><s>R4.10-We suggest not delaying any additional examinations or potentially nephrotoxic agent administration if they are needed to manage the patient.</s></p><p><s>(Experts opinion) STRONG agreement</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="5.">How to manage nephrotoxic agents?</head><p><s>R5.1-We suggest optimizing hydration using crystalloids to prevent contrast-induced nephropathy (CIN), ideally before contrast media infusion and to continue this therapy within 6-12 h after this infusion.</s></p><p><s>(Grade 2+) STRONG agreement R5.2-We suggest not using N-acetylcysteine (NAC) and/or sodium bicarbonate to prevent CIN.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>(Grade 2−) STRONG agreement</head><p><s>Rationale: Despite a small number of studies with poor methodology, using numerous different definitions, the incidence of CIN in non-ICUs varies from 2 % in patients without any risk factor <ref type="bibr" target="#b119">[120]</ref> to 25 % Finally, fluid vascular loading before procedures seems to be the most efficient preventive treatment for CIN with a largely positive benefit/risk ratio, provided one is careful in patients at high risk of decompensation following moderate fluid infusion.</s><s>while limiting toxicity <ref type="bibr" target="#b143">[144]</ref>.</s><s>This limitation does not apply to endovascular and osteoarticular infections with material, as well as endocarditis.</s><s>In these latter situations, the prolonged administration of aminoglycosides over several days or weeks may be needed.</s><s>Nevertheless, there is no study assessing the recommended usual strategy in these conditions.</s><s>This recommendation is an expert opinion issued from results based on older studies evaluating toxicity.</s></p><p><s>Despite the absence of randomized controlled studies evaluating the cumulative use of nephrotoxic agents, studies with cohorts of patients and those evaluating toxicity show that the association of several nephrotoxic risk factors, especially the accumulation of several nephrotoxic drugs, exponentially increases the risk of AKI <ref type="bibr" target="#b59">[60,</ref><ref type="bibr" target="#b60">61]</ref>.</s><s>This should be taken into account when choosing drugs for patients at risk of AKI by considering their indications and favouring essential drugs.</s><s>For example, non-steroidal antiinflammatory agents should be avoided in patients treated with both aminoglycosides and glycopeptides.</s><s>Only essential drugs and alternative strategies should be favoured for decreasing nephrotoxicity <ref type="bibr" target="#b150">[151]</ref><ref type="bibr" target="#b151">[152]</ref><ref type="bibr" target="#b152">[153]</ref>.</s></p><p><s>R5.3-We suggest administering aminoglycosides when necessary with respect to the following rules:</s></p><p><s>• administer them with single dosing per day,</s></p><p><s>• monitor their residual level in case of more than a single infusion, • administer them for a maximum of 3 days whenever possible.</s></p><p><s>(Grade 2+) STRONG agreement R5.4-We suggest not using non-steroidal anti-inflammatory drugs (NSAIs), converting enzyme inhibitors (CEIs), and angiotensin 2 receptor antagonists in patients at risk of AKI.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>(Experts opinion) STRONG agreement</head><p><s>Rationale: Studies showing renal and ear toxicity associated with aminoglycosides are old and based on a design of twice-daily administration without any consideration of residual serum concentration levels <ref type="bibr" target="#b139">[140]</ref><ref type="bibr" target="#b140">[141]</ref><ref type="bibr" target="#b141">[142]</ref>.</s><s>More recent studies have shown that toxicity was essentially related to high levels of residual serum concentration of the drug (more than 20 h after infusion), while the peak concentration (measured ½ h after infusion) was the parameter responsible for efficiency <ref type="bibr" target="#b142">[143]</ref><ref type="bibr" target="#b143">[144]</ref><ref type="bibr" target="#b144">[145]</ref><ref type="bibr" target="#b145">[146]</ref><ref type="bibr" target="#b146">[147]</ref><ref type="bibr" target="#b147">[148]</ref><ref type="bibr" target="#b148">[149]</ref><ref type="bibr" target="#b149">[150]</ref>.</s><s>Current recommendations are based on these later trials, favouring a high peak serum concentration using high doses of aminoglycoside as boluses and close monitoring of residual serum concentrations to avoid renal toxicity.</s><s>In practice, the determination of peak serum levels performed 30 min after the infusion of aminoglycosides should be used, and then, the following dose should be adapted in order to reach the recommended threshold.</s><s>For the problem of toxicity, if the aminoglycoside is used for several consecutive days, the evaluation of the residual serum level 24 h after its administration should be performed before infusing a new dose, provided the serum concentration is below the recommended threshold.</s><s>Moreover, it has been shown that prolonged exposure increases the occurrence of AKI, explaining the reason for limiting the duration of treatment to 3 days.</s><s>Such a strategy allows clinicians to be efficient during the acute phase of sepsis</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="6.">Pharmacological strategies for the preventive and curative treatment of AKI</head><p><s>R6.1-We recommend not using diuretics in order to prevent or treat AKI; we suggest using them for treating fluid overload.</s></p><p><s>(Grade 1−) STRONG agreement Rationale: AKI is a frequent organ failure in the ICU and during the perioperative period surrounding cardiovascular surgery and is associated with a high risk of morbidity and mortality.</s><s>In two recent metaanalyses <ref type="bibr" target="#b153">[154,</ref><ref type="bibr" target="#b154">155]</ref>, the administration of diuretics did not reduce the incidence and severity of AKI.</s><s>For this indication, furosemide did not demonstrate any benefit in terms of in-hospital mortality, the need for and the number of sessions of RRT.</s><s>Because AKI with fluid overload is associated with higher mortality rates <ref type="bibr" target="#b103">[104,</ref><ref type="bibr" target="#b106">107]</ref>, diuretics can be proposed for treating fluid overload.</s></p><p><s>R6.2-We suggest not using sodium bicarbonate to prevent or treat AKI (Grade 2−) STRONG agreement</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Rationale:</head><p><s>The prevention of AKI using sodium bicarbonate has been performed in a randomized controlled multicentre study (sodium bicarbonate vs 0.9 % sodium chloride) with a primary endpoint being the occurrence of AKI in the post-operative period <ref type="bibr" target="#b155">[156]</ref>.</s><s>The results found a higher incidence of AKI in the sodium bicarbonate group <ref type="bibr">(</ref>  <ref type="bibr" target="#b156">[157,</ref><ref type="bibr" target="#b157">158]</ref>.</s></p><p><s>Concerning the treatment of AKI, a recent metaanalysis has assessed the administration of sodium bicarbonate for this indication <ref type="bibr" target="#b158">[159]</ref>.</s><s>The primary endpoint was in-hospital mortality; secondary endpoints were the need for RRT, renal recovery and global survival.</s><s>Four studies were considered in this analysis, but none met the pre-defined criteria.</s><s>Consequently, taking into account data issued from current literature, we do not recommend the administration of sodium bicarbonate to prevent or treat AKI.</s></p><p><s>In the special condition of rhabdomyolysis-related AKI, fluid vascular loading requirements seem to be established <ref type="bibr" target="#b159">[160]</ref><ref type="bibr" target="#b160">[161]</ref><ref type="bibr" target="#b161">[162]</ref>, but the nature of the fluid remains in discussion.</s><s>Theoretical benefits for using sodium bicarbonate are described (inhibition of intrarenal vasoconstriction, inhibition of lipid peroxidation and decreases in myoglobin crystallization with Tamm-Horsfall protein).</s><s>Nevertheless, for methodological reasons (small size, multiple interventions, non-randomized studies), the rare availability of such studies cannot be used to confirm that sodium bicarbonate is superior to other solutions used for vascular loading <ref type="bibr" target="#b162">[163]</ref><ref type="bibr" target="#b163">[164]</ref><ref type="bibr" target="#b164">[165]</ref><ref type="bibr" target="#b165">[166]</ref><ref type="bibr" target="#b166">[167]</ref>.</s></p><p><s>Low-dose dopamine (1-3 µg/kg/min) induces renal vasodilation and natriuresis in healthy adults.</s><s>This agent has been evaluated as a preventive treatment for AKI in multiple clinical situations: critically ill patients with SIRS, the perioperative period for aortic surgery, the post-operative period following liver or kidney transplantation.</s><s>Most studies, which include a randomized, controlled multicentre trial, a meta-analysis and a systematic review, conclude that dopamine has no beneficial effect either in preventive or in the curative treatment of AKI <ref type="bibr" target="#b170">[171]</ref><ref type="bibr" target="#b171">[172]</ref><ref type="bibr" target="#b172">[173]</ref>.</s></p><p><s>Fenoldopam is a dopamine-1 receptor agonist without α or β adrenergic systemic effects.</s><s>Seven studies have included 1218 patients and did not find beneficial effects associated with the preventive or curative administration of fenoldopam as concerns mortality and the need for RRT <ref type="bibr" target="#b173">[174]</ref><ref type="bibr" target="#b174">[175]</ref><ref type="bibr" target="#b175">[176]</ref><ref type="bibr" target="#b176">[177]</ref><ref type="bibr" target="#b177">[178]</ref><ref type="bibr" target="#b178">[179]</ref><ref type="bibr" target="#b179">[180]</ref>.</s><s>The benefit of fenoldopam in terms of AKI occurrence is difficult to evaluate due to heterogenous delays in administration and diagnosis criteria among studies.</s><s>Four meta-analyses are available but show conflicting results: two of them reported a beneficial effect with a reduction in the risk of AKI, one did not find any beneficial effect and the last one did not analyse the risk of AKI <ref type="bibr" target="#b180">[181]</ref><ref type="bibr" target="#b181">[182]</ref><ref type="bibr" target="#b182">[183]</ref><ref type="bibr" target="#b183">[184]</ref>. Considering current data in the literature, it is recommended not to use fenoldopam for the prevention or treatment of AKI.</s></p><p><s>Several natriuretic peptides that can increase GFR have been proposed as preventive and curative therapies for AKI.</s><s>Most of the prospective randomized controlled trials and 3 meta-analyses have not found any benefit associated with these agents <ref type="bibr" target="#b184">[185]</ref><ref type="bibr" target="#b185">[186]</ref><ref type="bibr" target="#b186">[187]</ref><ref type="bibr" target="#b187">[188]</ref>.</s></p><p><s>The preventive or curative administration of NAC for AKI has not demonstrated any beneficial effect concerning the need for RRT and reductions in mortality <ref type="bibr" target="#b128">[129,</ref><ref type="bibr" target="#b188">[189]</ref><ref type="bibr" target="#b189">[190]</ref><ref type="bibr" target="#b190">[191]</ref><ref type="bibr" target="#b191">[192]</ref>. Apart for preventing CIN, studies were performed essentially in the perioperative period of cardiovascular surgery.</s></p><p><s>Based on the available studies, no beneficial effect associated with the preventive and curative administration of IGF-1 has been demonstrated for AKI <ref type="bibr" target="#b192">[193,</ref><ref type="bibr" target="#b193">194]</ref>.</s><s>Currently, there are not enough data to recommend erythropoietin for preventing or treating AKI <ref type="bibr" target="#b194">[195]</ref>.</s><s>Only one study including 171 patients undergoing cardiac surgery (coronary artery bypass graft) has shown that erythropoietin (300 U/kg) administered before cardiac surgery for coronary artery bypass grafts, enabled a reduction in the risk of post-operative AKI compared with 0.9 % saline solution (8 vs 29 %, p = 0.03) <ref type="bibr" target="#b195">[196]</ref>.</s></p><p><s>In two pilot studies, rolofylline (an antagonist of A 1 adenosine receptors) versus placebo was administered R6.3-We recommend not using the following treatments to prevent or treat AKI: mannitol, dopamine, fenoldopam, atrial natriuretic factor, NAC, insulinlike growth factor-1 (IGF-1), erythropoietin, adenosine receptor antagonists.</s></p><p><s>(Grade 1−) STRONG agreement Rationale: Mannitol has been proposed as a preventive treatment of AKI during the perioperative period in traumatic brain injury, in patients with rhabdomyolysis or those undergoing coronarography.</s><s>In most studies, it increases urine output while increasing or not decreasing the incidence of AKI <ref type="bibr" target="#b167">[168]</ref><ref type="bibr" target="#b168">[169]</ref><ref type="bibr" target="#b169">[170]</ref>.</s></p><p><s>in patients with acute cardiac insufficiency <ref type="bibr" target="#b196">[197,</ref><ref type="bibr" target="#b197">198]</ref>.</s><s>Both found that rolofylline increased urine output and improved creatinine clearance (vs placebo).</s><s>The largest and more recent prospective multicentre trial (n = 2033 patients) comparing rolofylline versus placebo in patients with acute cardiac insufficiency did not find beneficial effect of rolofylline in terms of survival, cardiac and renal function <ref type="bibr" target="#b198">[199]</ref>.</s></p><p><s>There are two special conditions requiring the preventive treatment of AKI: (1) high doses of methotrexate infusion <ref type="bibr" target="#b199">[200]</ref>; (2) patients with a high risk of tumour lysis syndrome.</s><s>Methotrexate at high doses (1-12 g/m 2 ) is a treatment required for numerous malignant tumours.</s><s>This drug can induce AKI (up to 40 % of patients in a recent study), which is due to direct tubular toxicity and intratubular precipitation <ref type="bibr" target="#b200">[201]</ref>.</s><s>Intravenous hydration (≥2 l/m 2 ) and urine alkalinization are both recommended strategies for preventing AKI.</s><s>Several historical observational and interventional studies highlighted that these strategies were associated with an increased methotrexate clearance and decreased episodes of severe toxicity <ref type="bibr" target="#b201">[202]</ref><ref type="bibr" target="#b202">[203]</ref><ref type="bibr" target="#b203">[204]</ref><ref type="bibr" target="#b204">[205]</ref>. Urine alkalinization decreases methotrexate crystallization <ref type="bibr" target="#b201">[202]</ref>.</s><s>Thus, it is recommended to alkalinize the urine of patients who must receive high doses of methotrexate (1-12 g/m 2 ) in order to prevent AKI.</s><s>About one-third of patients with a high risk of tumour lysis syndrome develop AKI <ref type="bibr" target="#b205">[206,</ref><ref type="bibr" target="#b206">207]</ref>.</s><s>In this clinical condition, hyperuricaemia is one of the factors which contribute to AKI by different mechanisms <ref type="bibr" target="#b207">[208]</ref>.</s><s>In two randomized controlled studies and 2 recent metaanalyses, rasburicase administration was associated with a more rapid and profound decrease in uricaemia as compared with allopurinol <ref type="bibr" target="#b208">[209]</ref><ref type="bibr" target="#b209">[210]</ref><ref type="bibr" target="#b210">[211]</ref>.</s><s>However, there is no proof that rasburicase is associated with reduced AKI incidence <ref type="bibr" target="#b211">[212]</ref>.</s><s>Hyperuricaemia is only one of the numerous mechanisms implicated in renal injury during tumour lysis syndrome (phosphate and calcium crystals, hypovolaemia, renal tumour infiltration, nephrotoxic exposure, inflammation).</s><s>In patients with a high risk of tumour lysis syndrome, rasburicase administration is proposed by four recent expert recommendations <ref type="bibr" target="#b197">[198,</ref><ref type="bibr" target="#b212">[213]</ref><ref type="bibr" target="#b213">[214]</ref><ref type="bibr" target="#b214">[215]</ref>. R7.2-We recommend not limiting nutritional support in order to only prevent fluid overload and/or the need for renal replacement therapy.</s></p><p><s>(Grade 1−) STRONG agreement</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="7.">Nutritional modalities for AKI</head><p><s>R7.1-We suggest following the same nutritional strategy rules in critically ill patients whether or not they have AKI (without renal replacement therapy).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>(Grade 2+) STRONG agreement</head><p><s>Rationale: AKI has an impact on fluid balance and acidbase equilibrium, but also interferes with the metabolism of each macronutrient, generally towards hypercatabolism.</s><s>Thus, the consequences of AKI on nutrition add to those related to the underlying pathology <ref type="bibr" target="#b215">[216]</ref>.</s><s>In patients with AKI, undernutrition is significantly associated with a high incidence of infectious complications, prolonged in-hospital length of stay and mortality <ref type="bibr" target="#b17">[18]</ref>.</s><s>Nutritional evaluation is complex because normally available markers (body mass index, impedancemetry) become inaccurate due to modifications in hydration status <ref type="bibr" target="#b216">[217]</ref>.</s><s>Nutritional support in injured patients with or without AKI must be similar, aiming at an appropriate energy and protein intake, muscle mass preservation, improvement in immune function and reduction in mortality <ref type="bibr" target="#b217">[218]</ref>.</s><s>Nutritional requirements must take into account hypercatabolism related to illness and the presence or not of RRT and its technique.</s><s>These parameters, more than AKI itself, have a major impact on nutritional strategies.</s><s>Indirect calorimetry remains the reference tool required to define patient energy requirements.</s><s>When this device cannot be used, it is recommended to provide an energy target of 20-30 kcal/kg/day and a protein target of 1.5 g/kg/day, in the absence of RRT <ref type="bibr" target="#b218">[219]</ref>.</s><s>In case of RRT, an increase in protein supply including glutamine and micronutrients (vitamins and trace elements) is suggested <ref type="bibr" target="#b219">[220]</ref>.</s><s>Water-soluble vitamins from the B group (especially B1 vitamins and folates) are significantly eliminated during RRT <ref type="bibr" target="#b220">[221]</ref>.</s></p><p><s>R7.1 Paediatric-We suggest adapting protein intake according to the age of children with AKI.</s></p><p><s>(Grade 2+) STRONG agreement Paediatric rationale: KDIGO recommendations in 2012 <ref type="bibr" target="#b0">[1]</ref> have elaborated recommendations for the nutrition of paediatric patients with AKI that can be followed.</s><s>The authors insist on the essential point for paediatric patients, i.e. the dynamics of growth and weight gain, which justify a higher nutrition intake than in adults.</s><s>The KDIGO recommendations have proposed the following protein intake depending on the age of children presenting with AKI:</s></p><p><s>• 2-3 g/kg/day from 0 to 2 years, • 1.5-2 g/kg/day from 2 to 13 years, • 1.5 g/kg/day above 13 years.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="8.">How to evaluate kidney functional recovery after AKI</head><p><s>Authors' contributions CI and LV proposed the elaboration of this recommendation and manuscript in agreement with the "Société Française d' Anesthésie et de Réanimation" &amp; "Société de Réanimation de Langue Française"; they wrote the methology section and gave the final version with the final presentation.</s><s>AL, TR, AG, TG contributed to elaborate recommendations and write the rationale of question 1. JMC, LJ, MD, JD, NL contributed to elaborate recommendations and to write the rationale of question 2. CC, ML contributed to elaborate recommendations and to write the rationale of question 3. MD, LM contributed to elaborate recommendations and to write the rationale of question 4. MD, OJB contributed to elaborate recommendations and to write the rationale of question 5. EC, DJ, AG, TG contributed to elaborate recommendations and to write the rationale of question 6. FT, BS, AG, TG contributed to elaborate recommendations and to write the rationale of question 7. ER, CV contributed to elaborate recommendations and to write the rationale of question 8. FA, YW provide references.</s><s>All authors read and approved the final manuscript.</s></p><p><s>Author details 1 Service de Réanimation Polyvalente, IRCAN (Inserm U1081, CNRS UMR7284 et CHU de Nice, Hôpital Pasteur 2, 30 Voie Romaine, CHU de Nice, 06000 Nice, France. 2 Service de Réanimation, Hôpital Marc Jacquet, 77000 Melun, France. 3 Service de Réanimation Polyvalente, CHU de Nice, 30 Voie Romaine, 06000 Nice, France. 4 Service de Réanimation médicale, CHU de Clermont-Ferrand, 63000 Clermont-Ferrand, France. 5 Service de Réanimation, Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Louis, 1 Avenue Claude Vellefaux, 75010 Paris, France. 6</s><s>Service de Réanimation, Assistance Publique-Hôpitaux de Paris, Hôpital d' Avicenne, 125 rue de Stalingrad, 93000 Bobigny, France. 7</s><s>Département de Médecine périopératoire, Hôpital Estaing, CHU de Clermont-Ferrand, 1 place Louis Aubrac, 63000 Clermont-Ferrand, France. 8</s><s>Service de réanimation, hôpital de la Charité, CHU de Saint-Etienne, 44 rue Pointe Cadet, 42100 Saint-Etienne, France. 9</s><s>Département d'anesthésie-réanimation, Assistance Publique-Hôpitaux de Paris, hôpital Kremlin-Bicêtre, 78, rue de la division du général Leclerc, 94270 Le Kremlin-Bicêtre, France. 10 Service de Pédiatrie, hôpital Sud, CHU de Rennes, 16 Bd Bulgarie, 35203 Rennes, France. 11</s><s>Service de Pédiatrie, Néphrologie, hôpital des Enfants, CHU de Toulouse, 330 avenue de Grande-Bretagne, 31059 Toulouse Cedex, France. 12</s><s>Service d'anesthésie-réanimation, Assistance Publique-Hôpitaux de Paris, hôpital Saint-Louis, 1, Avenue Claude-Vellefaux, 75010 Paris, France. 13</s><s>Service d' Anesthésie Réanimation II, Hôpital du Haut-Lévêque, CHU de Bordeaux, 33600 Pessac, France. 14</s><s>Service de néphrologie-dialyse, hôpital Édouard-Herriot, Hospices Civils de Lyon, 5, Place d' Arsonval, 69003 Lyon, France. 15</s><s>Service de réanimation, Assistance Publique-Hôpitaux de Paris, hôpital Européen Georges Pompidou, 20, rue Leblanc, 75908 Paris, France. 16</s><s>Service de réanimation, hôpital Gabriel Montpied, CHU de Clermont-Ferrand, 58 rue Montalemberg, 63003 Clermont-Ferrand, France. 17</s><s>Service de réanimation, hôpital Carémeau, CHU de Nîmes, 4 rue du Professeur Robert-Debré, 30029 Nîmes, France. 18</s><s>Service d'anesthésie-réanimation, hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, 1, Avenue Claude-Vellefaux, 75010 Paris, France. 19</s><s>Service de réanimation, centre hospitalier universitaire, CHU d' Angers, 4 rue Larrey, 49100 Angers, France. 20</s><s>Service d'anesthésie réanimation, hôpital Édouard-Herriot, Hospices Civils de Lyon, 5, Place d' Arsonval, 69003 Lyon, France. 21</s><s>Service de néphrologie, hôpital Tenon, Assistance Publique-Hôpitaux de Paris, 4, rue de la Chine, 75020 Paris, France. 22</s><s>Service de réanimation médicale, hôpital Charles-Nicolle, CHU de Rouen, 1 rue de Germont, 76031 Rouen, France. 23</s><s>Service d'anesthésie-réanimation, hôpital de la Timone, Assistance Publique-Hôpitaux de Marseille, 13385 Marseille Cedex 5, France.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>R2. 2 -</head><label>2</label><figDesc><div><p><s>We suggest not to use the Doppler renal resistive index to diagnose or treat AKI.(Grade 2−) STRONG agreement</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>R4. 6 -</head><label>6</label><figDesc><div><p><s>We recommend monitoring and optimizing systolic ejection volume or derived parameters during the perioperative period in order to guide vascular fluid loading.</s><s>(Grade 1+) STRONG agreement R4.7-We suggest applying the same recommendations in the ICU.</s><s>(Grade 2+) STRONG agreement R4.8-After haemodynamic stabilization, we suggest avoiding fluid overload in the ICU.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table 1</head><label>1</label><figDesc></figDesc><table><row><cell>5 ml/kg/h for 6-12 h</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_2"><head>Estimated plasma creatinine clearance Urine output</head><label></label><figDesc></figDesc><table><row><cell>Risk</cell><cell>Decrease &gt;25 %</cell><cell>&lt;0.5 ml/kg/h during</cell></row><row><cell></cell><cell></cell><cell>&gt;8 h</cell></row><row><cell>Injury</cell><cell>Decrease &gt;50 %</cell><cell>&lt;0.5 ml/kg/h during</cell></row><row><cell></cell><cell></cell><cell>&gt;16 h</cell></row><row><cell>Failure</cell><cell>Decrease &gt;75 % or</cell><cell>&lt;0.3 ml/kg/h during</cell></row><row><cell></cell><cell>&lt;35 ml/min/1.73 m 2</cell><cell>24 h or anuria &gt;12 h</cell></row><row><cell>Loss</cell><cell>Grade «failure» persist-</cell><cell></cell></row><row><cell></cell><cell>ing for &gt;4 weeks</cell><cell></cell></row><row><cell>End stage (chronic renal</cell><cell>Grade «failure» persist-</cell><cell></cell></row><row><cell>insufficiency)</cell><cell>ing for &gt;3 months</cell><cell></cell></row><row><cell>R1.1 Paediatrics-In paediatric patients, we suggest</cell><cell></cell><cell></cell></row><row><cell>using the RIFLE classification modified for paediat-</cell><cell></cell><cell></cell></row><row><cell>ric patients (pRIFLE) for diagnosing AKI: a decrease ≥25 % of estimated creatinine clearance or urine out-put &lt;0.5 ml/kg/h during 8 h.</cell><cell></cell><cell></cell></row><row><cell>(Expert opinion) STRONG Agreement</cell><cell></cell><cell></cell></row><row><cell>R1.2 Paediatrics-In paediatric patients, we suggest</cell><cell></cell><cell></cell></row><row><cell>evaluating the severity of AKI by using the criteria of</cell><cell></cell><cell></cell></row><row><cell>the pRIFLE classification.</cell><cell></cell><cell></cell></row><row><cell>(Experts opinion) STRONG Agreement</cell><cell></cell><cell></cell></row><row><cell>Rationale: In 2012, KDIGO recommendations for defining AKI were formulated for both adult and pae-</cell><cell></cell><cell></cell></row><row><cell>diatric patients. However, RIFLE and AKIN criteria</cell><cell></cell><cell></cell></row><row><cell>are not really appropriate for children as they do not</cell><cell></cell><cell></cell></row><row><cell>take into account the large variations in body mass</cell><cell></cell><cell></cell></row><row><cell>index found in these patients. Moreover, because</cell><cell></cell><cell></cell></row><row><cell>muscle mass is lower in children than in adults, Scr</cell><cell></cell><cell></cell></row><row><cell>values are not a good marker of paediatric AKI. Con-</cell><cell></cell><cell></cell></row><row><cell>sequently, a paediatric RIFLE classification (pRIFLE)</cell><cell></cell><cell></cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_3"><head>Table 3 Major risk factors for AKI related to patient sus- ceptibilities and/or to exposures in hospitalized patients</head><label>3</label><figDesc></figDesc><table><row><cell>Underlying susceptibilities</cell><cell>Procedures/exposures</cell></row><row><cell>Age ≥65 years a Chronic kidney disease a</cell><cell>Sepsis a Haemodynamic instability</cell></row><row><cell>Male</cell><cell>Perioperative period a</cell></row><row><cell></cell><cell>Major surgery a (emergency,</cell></row><row><cell></cell><cell>abdominopelvic, cardiovascular,</cell></row><row><cell></cell><cell>thoracic, bleeding surgeries)</cell></row><row><cell>African origin</cell><cell>Severe burn</cell></row><row><cell>Obesity (BMI &gt;40 kg/m 2 )</cell><cell>Severe trauma</cell></row><row><cell>Arterial hypertension</cell><cell>Nephrotoxic agents (drugs,</cell></row><row><cell></cell><cell>radiocontrast agents)</cell></row><row><cell>Congestive cardiac insufficiency</cell><cell></cell></row><row><cell>Hepatocellular insufficiency</cell><cell></cell></row><row><cell>Severe respiratory insufficiency</cell><cell></cell></row><row><cell>Diabetes</cell><cell></cell></row><row><cell>Cancer</cell><cell></cell></row><row><cell>Anaemia</cell><cell></cell></row></table><note><p><s>a Most important risk factors</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_4"><head>Table 4 Major nephrotoxic agents responsible for AKI in ICUs and in the perioperative period</head><label>4</label><figDesc></figDesc><table><row><cell>Radiocontrast agents</cell></row><row><cell>Aminoglycosides</cell></row><row><cell>Amphotericin</cell></row><row><cell>Non-steroidal anti-inflammatory agents</cell></row><row><cell>β-Lactams (interstitial nephropathies)</cell></row><row><cell>Sulfamides</cell></row><row><cell>Aciclovir, methotrexate, cisplatin</cell></row><row><cell>Cyclosporin, tacrolimus</cell></row><row><cell>Angiotensin-converting-enzyme inhibitors (ACE)</cell></row></table></figure>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Acknowledgements</head></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Competing interests</head><p><s>Christophe VINSONNEAU declares funding and speaker fees from ASTUTE MEDICAL, transport accommodation from FRESENIUS MEDICAL and HOSPAL GAMBRO.</s><s>Olivier JOANNES-BOYAU declares consulting fees from BAXTER, BBRAUN.</s><s>Laurent MULLER declares speaker and reimbursement fees from FRESENIUS KABI and BBRAUN.</s><s>Matthieu LEGRAND declares speaker fees from ALERE, funding fees from ASTUTE, BRAHMS, ABBOTT, GAMBRO-HOSPAL.</s><s>Eric RONDEAU declares consulting or funding fees from NOVARTIS, ASTELLAS, R8.1-We recommend considering patients with AKI as patients at high risk of developing CRI.</s></p><p><s>(Grade 1+) STRONG agreement R8.2-We suggest assessing renal function in patients who presented AKI 6 months after the acute episode.</s></p><p><s>(Grade 2+) STRONG agreement R8.3-We suggest defining the absence of renal functional recovery following AKI as follows: an increase in Scr above 25 % of its basal value or RRT dependancy.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>(Grade 2+) STRONG agreement</head><p><s>Rationale: Severe AKI can be associated with a total or partial absence of renal functional recovery, leading to CRI.</s><s>Paediatric studies using long-term follow-up were the first to show that patients considered as completely recovered based on biological data can progress towards CRI within the 3 following years in 10 % of cases <ref type="bibr" target="#b221">[222]</ref>.</s><s>An incomplete recovery can lead to a normalization of the usual biological parameters (Scr), despite a decreased number of nephrons.</s><s>This phenomenon leads to higher renal susceptibility in case of a new injury or during physiological ageing.</s></p><p><s>A recent review estimates the incidence of CRI after an acute injury at 25.8/100 patient-years and the incidence of end-stage kidney disease at 6.6/100 patientyears <ref type="bibr" target="#b9">[10]</ref>.</s><s>Thus, it is clear that there is a relationship between AKI and CRI.</s><s>Moreover, several studies report that there is also a relationship between the severity of AKI and the increased risk of chronic damage with a twofold increase in end-stage CRI requiring dialysis at 10 years <ref type="bibr" target="#b222">[223]</ref>.</s><s>This evolution towards CRI is associated with an increased mortality rate.</s><s>The study of Pannu et al. <ref type="bibr" target="#b223">[224]</ref> found that as soon as renal function recovery remains below 125 % of pre-injured Scr, a nephrologic follow-up is required in order to detect long-term poor renal functional recovery.</s><s>A study assessed 3877 patients and, among them, 1153 were followed for 3 months by a nephrologist.</s><s>This study found that these patients had a significantly higher survival compared with the matched control group (RR 0.76, 95 % CI 0.62-0.93)</s><s><ref type="bibr" target="#b224">[225]</ref>.</s><s>Therefore, a systematic follow-up by nephrologists is advised in patients who present with AKI, regardless of their early renal function recovery.</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">The Kidney Disease Improving Global Outcomes (KDIGO) Working Group. KDIGO clinical practice guideline for acute kidney injury</title>
	</analytic>
	<monogr>
		<title level="j">Kidney Int Suppl</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page" from="1" to="138" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Assessment of renal function in recently admitted critically ill patients with normal serum creatinine</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Hoste</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Damen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">C</forename><surname>Vanholder</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nephrol Dial Transplant</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="page" from="747" to="753" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (part 1)</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Kellum</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Lameire</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Crit Care</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page">204</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Acute renal failure-definition, outcome measures, animal models, fluid therapy and information technology needs: the second international consensus conference of the Acute Dialysis Quality Initiative (ADQI) Group</title>
		<author>
			<persName><forename type="first">R</forename><surname>Bellomo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Ronco</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Kellum</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Mehta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Palevsky</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Crit Care</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="R204" to="212" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Acute kidney injury network: report of an initiative to improve outcomes in acute kidney injury</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Mehta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Kellum</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">V</forename><surname>Shah</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Crit Care</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page">R31</biblScope>
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">An assessment of the RIFLE criteria for acute renal failure in hospitalized patients</title>
		<author>
			<persName><forename type="first">S</forename><surname>Uchino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Bellomo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Goldsmith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Bates</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Ronco</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Crit Care Med</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="page" from="1913" to="1917" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients: a cohort analysis</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Hoste</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Clermont</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Kersten</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Crit Care</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page">R73</biblScope>
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">A multi-centre evaluation of the RIFLE criteria for early acute kidney injury in critically ill patients</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Bagshaw</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>George</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Dinu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Bellomo</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nephrol Dial Transplant</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page" from="1203" to="1210" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Acute kidney injury in critically ill patients classified by AKIN versus RIFLE using the SAPS 3 database</title>
		<author>
			<persName><forename type="first">M</forename><surname>Joannidis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Metnitz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Bauer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Intensive Care Med</title>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="page" from="1692" to="1702" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">G</forename><surname>Coca</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Singanamala</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">R</forename><surname>Parikh</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Kidney Int</title>
		<imprint>
			<biblScope unit="volume">81</biblScope>
			<biblScope unit="page" from="442" to="448" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Modified RIFLE criteria in critically ill children with acute kidney injury</title>
		<author>
			<persName><forename type="first">A</forename><surname>Akcan-Arikan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Zappitelli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">L</forename><surname>Loftis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">K</forename><surname>Wasburn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">S</forename><surname>Jefferson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">L</forename><surname>Goldstein</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Kidney Int</title>
		<imprint>
			<biblScope unit="volume">71</biblScope>
			<biblScope unit="page" from="1028" to="1035" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">J</forename><surname>Schwartz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">P</forename><surname>Brion</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Spitzer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Pediatr Clin N Am</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="page" from="57" to="90" />
			<date type="published" when="1987">1987</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Pediatric acute kidney injury in the ICU: an independent evaluation of pRIFLE criteria</title>
		<author>
			<persName><forename type="first">F</forename><surname>Plötz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Bouma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Van Wijk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kneyber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Bökenkamp</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Intensive Care Med</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="page" from="1713" to="1717" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Cellular pathophysiology of ischemic acute kidney injury</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">V</forename><surname>Bonventre</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Yang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Invest</title>
		<imprint>
			<biblScope unit="volume">121</biblScope>
			<biblScope unit="page" from="4210" to="4221" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Acute kidney Inj</title>
		<author>
			<persName><forename type="first">R</forename><surname>Bellomo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Kellum</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Ronco</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">380</biblScope>
			<biblScope unit="page" from="7556" to="7566" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Acute kidney injury, mortality, length of stay and costs in hospitalized patients</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">M</forename><surname>Chertow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Burdock</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Honour</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Am Soc Nephrol</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page" from="3365" to="3370" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Chronic dialysis and death among survivors of acute kidney injury requiring dialysis</title>
		<author>
			<persName><forename type="first">R</forename><surname>Wald</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">R</forename><surname>Quinn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Luo</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">JAMA</title>
		<imprint>
			<biblScope unit="volume">302</biblScope>
			<biblScope unit="page" from="1179" to="1185" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Acute renal failure in critically ill patients: a multinational, multicenter study</title>
		<author>
			<persName><forename type="first">S</forename><surname>Uchino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Kellum</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Bellomo</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">JAMA</title>
		<imprint>
			<biblScope unit="volume">294</biblScope>
			<biblScope unit="page" from="813" to="818" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Diagnosis, epidemiology and outcomes of acute kidney injury</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">S</forename><surname>Waikar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">D</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">M</forename><surname>Chertow</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin J Am Soc Nephrol</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page" from="844" to="861" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Incidence, risk factors and 90-day mortality of patients with acute kidney injury in Finnish intensive care units: the FINNAKI study</title>
		<author>
			<persName><forename type="first">S</forename><surname>Nisula</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K-M</forename><surname>Kaukonen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">T</forename><surname>Vaara</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Intensive Care Med</title>
		<imprint>
			<biblScope unit="volume">39</biblScope>
			<biblScope unit="page" from="420" to="428" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">for the Finnish Intensive Care Consortium. Population-based incidence, and mortality and quality of life in critically ill patients treated with renal replacement therapy: a nationwide retrospective cohort study in finnish intensive care units</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">T</forename><surname>Vaara</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Pettilä</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Reinkainen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K-M</forename><surname>Kaukonen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Crit Care</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page">R13</biblScope>
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Clearance and beyond: the complementary roles of GFR measurement and injury biomarkers in acute kidney injury (AKI)</title>
		<author>
			<persName><forename type="first">Z</forename><forename type="middle">H</forename><surname>Endre</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename><surname>Pickering</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Walker</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Physiol Renal Physiol</title>
		<imprint>
			<biblScope unit="volume">301</biblScope>
			<biblScope unit="page" from="F697" to="707" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Current use of biomarkers in acute kidney injury: report and summary of recommendations from the 10th acute dialysis quality initiative consensus conference</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">T</forename><surname>Murray</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Mehta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Shaw</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Kidney Int</title>
		<imprint>
			<biblScope unit="volume">85</biblScope>
			<biblScope unit="page" from="513" to="521" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Acute kidney injury in 2014: a step towards understanding mechanism of renal repair</title>
		<author>
			<persName><forename type="first">A</forename><surname>Bihorac</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Kellum</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Rev Nephrol</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="74" to="75" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Acute kidney injury in 2013: breaking barriers for biomarkers in AKI-progress at last</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">N</forename><surname>Cruz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Mehta</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Rev Neprhol</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="74" to="76" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">New biomarkers in acute kidney injury</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">R</forename><surname>Parikh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Devarajan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Crit Care Med</title>
		<imprint>
			<biblScope unit="volume">36</biblScope>
			<biblScope unit="page" from="S159" to="S165" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Cystatin C in prediction of acute kidney injury: a systemic review and meta-analysis</title>
		<author>
			<persName><forename type="first">Z</forename><surname>Shang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Lu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Sheng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Jin</forename><forename type="middle">N</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Kidney Dis</title>
		<imprint>
			<biblScope unit="volume">58</biblScope>
			<biblScope unit="page" from="356" to="365" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Urinary interleukin 18 for detection of acute kidney injury: a metanalysis</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Guo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Zhang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Kidney Dis</title>
		<imprint>
			<biblScope unit="volume">62</biblScope>
			<biblScope unit="page" from="1058" to="1067" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Diagnostic value of urinary kidney injury molecule 1 for acute kidney injury: a meta-analysis</title>
		<author>
			<persName><forename type="first">X</forename><surname>Shao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Tian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Xu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS One</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page">e84131</biblScope>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and meta-analysis</title>
		<author>
			<persName><forename type="first">M</forename><surname>Haase</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Bellomo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Devarajan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Kidney Dis</title>
		<imprint>
			<biblScope unit="volume">54</biblScope>
			<biblScope unit="page" from="1012" to="1024" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">The outcome of neutrophil gelatinase-associated lipocalin-positive subclinical acute kidney injury</title>
		<author>
			<persName><forename type="first">M</forename><surname>Haase</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Devarajan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Haase-Fielitz</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">JACC</title>
		<imprint>
			<biblScope unit="volume">57</biblScope>
			<biblScope unit="page" from="1752" to="1761" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury</title>
		<author>
			<persName><forename type="first">K</forename><surname>Kashani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Al-Khafaji</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Ardiles</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Crit Care</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page">R25</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Validation of cell-cycle arrest biomarkers for acute kidney injury using clinical adjudication</title>
		<author>
			<persName><forename type="first">A</forename><surname>Bihorac</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">S</forename><surname>Chawla</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">D</forename><surname>Shaw</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Resp Crit Care Med</title>
		<imprint>
			<biblScope unit="volume">189</biblScope>
			<biblScope unit="page" from="932" to="939" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Biomarkers of acute kidney injury: an evolving domain</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">R</forename><surname>Mcillroy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Epi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Wagener</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">T</forename><surname>Lee</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Anesthesiology</title>
		<imprint>
			<biblScope unit="volume">112</biblScope>
			<biblScope unit="page" from="998" to="1004" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Acute kidney injury in children and its potential consequences in adulthood</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">L</forename><surname>Goldstein</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood Purif</title>
		<imprint>
			<biblScope unit="volume">33</biblScope>
			<biblScope unit="page" from="131" to="137" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">Urinary biomarkers and acute kidney injury in children: the long road to clinical application</title>
		<author>
			<persName><forename type="first">H</forename><surname>Schiffl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Lang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Pediatr Nephrol</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="page" from="837" to="842" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Early detection of acute kidney injury by serum cystatin C in critically ill children</title>
		<author>
			<persName><forename type="first">N</forename><surname>Ataei</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Bazargani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Sonbol</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Pediatr Nephrol</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="page" from="133" to="138" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Renal Doppler to assess renal perfusion in the critically ill: a reappraisal</title>
		<author>
			<persName><forename type="first">D</forename><surname>Schnell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Darmon</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Intensive Care Med</title>
		<imprint>
			<biblScope unit="volume">38</biblScope>
			<biblScope unit="page" from="1751" to="1760" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">Doppler monitoring of renal hemodynamics: why the best is yet to come</title>
		<author>
			<persName><forename type="first">J</forename><surname>Duranteau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Deruddre</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Vigue</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Chemla</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Intensive Care Med</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="page" from="1360" to="1361" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">An assessment of the accuracy of renal blood flow estimation by Doppler ultrasound</title>
		<author>
			<persName><forename type="first">L</forename><surname>Wan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C-Y</forename><surname>Hiew</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Intensive Care Med</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="page" from="1503" to="1510" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">Low-dose&quot; dopamine worsens renal perfusion in patients with acute renal failure</title>
		<author>
			<persName><forename type="first">A</forename><surname>Lauschke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Ukm</forename><surname>Teichgräber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Frei</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">U</forename><surname>Eckardt</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Kidney Int</title>
		<imprint>
			<biblScope unit="volume">69</biblScope>
			<biblScope unit="page" from="1669" to="1674" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">Renal arterial resistance in septic shock: effects of increasing mean arterial pressure with norepinephrine on the renal resistive index assessed with Doppler ultrasonography</title>
		<author>
			<persName><forename type="first">S</forename><surname>Deruddre</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Cheisson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">X</forename><surname>Mazoit</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Intensive Care Med</title>
		<imprint>
			<biblScope unit="volume">33</biblScope>
			<biblScope unit="page" from="1557" to="1562" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">renal perfusion assessment by renal doppler during fluid challenge in sepsis</title>
		<author>
			<persName><forename type="first">D</forename><surname>Schnell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Camous</surname></persName>
		</author>
		<author>
			<persName><forename type="first">'</forename><surname>Guyomarc</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Crit Care Med</title>
		<imprint>
			<biblScope unit="volume">41</biblScope>
			<biblScope unit="page" from="1214" to="1220" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main">Renal failure in septic shock: predictive value of Doppler-based renal arterial resistive index</title>
		<author>
			<persName><forename type="first">N</forename><surname>Lerolle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Guérot</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Faisy</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Intensive Care Med</title>
		<imprint>
			<biblScope unit="volume">32</biblScope>
			<biblScope unit="page" from="1553" to="1555" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">Acute renal failure: possible role of duplex Doppler US in distinction between acute prerenal failure and acute tubular necrosis</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">F</forename><surname>Platt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Rubin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Ellis</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Radiology</title>
		<imprint>
			<biblScope unit="volume">179</biblScope>
			<biblScope unit="page" from="419" to="423" />
			<date type="published" when="1991">1991</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main">Differential diagnosis of prerenal azotemia from acute tubular necrosis and prediction of recovery by Doppler ultrasound</title>
		<author>
			<persName><forename type="first">M</forename><surname>Izumi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Sugiura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Nakamura</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Kidney Dis</title>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="page" from="713" to="719" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main">Noninvasive monitoring of renal blood flow characteristics during acute renal failure in man</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">E</forename><surname>Stevens</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Gwyther</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Hanson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Intensive Care Med</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page" from="153" to="158" />
			<date type="published" when="1990">1990</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main">Renal resistive index better predicts the occurrence of acute kidney injury than cystatin C</title>
		<author>
			<persName><forename type="first">D</forename><surname>Schnell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Deruddre</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Harrois</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Shock</title>
		<imprint>
			<biblScope unit="volume">38</biblScope>
			<biblScope unit="page" from="592" to="597" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main">Diagnostic accuracy of Doppler renal resistive index for reversibility of acute kidney injury in critically ill patients</title>
		<author>
			<persName><forename type="first">M</forename><surname>Darmon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Schortgen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Vargas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Intensive Care Med</title>
		<imprint>
			<biblScope unit="volume">37</biblScope>
			<biblScope unit="page" from="68" to="76" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<title level="a" type="main">Resistive index or color-Doppler semi-quantitative evaluation of renal perfusion by inexperienced physicians: results of a pilot study</title>
		<author>
			<persName><forename type="first">D</forename><surname>Schnell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Reynaud</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Venot</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Minerva Anestesiol</title>
		<imprint>
			<biblScope unit="volume">80</biblScope>
			<biblScope unit="page" from="1273" to="1281" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b50">
	<analytic>
		<title level="a" type="main">Early detection of postoperative acute kidney injury by Doppler renal resistive index in cardiac surgery with cardiopulmonary bypass</title>
		<author>
			<persName><forename type="first">G</forename><surname>Bossard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Bourgoin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Corbeau</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Br J Anaesth</title>
		<imprint>
			<biblScope unit="volume">107</biblScope>
			<biblScope unit="page" from="891" to="898" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b51">
	<analytic>
		<title level="a" type="main">Doppler resistive index to reflect regulation of renal vascular tone during sepsis and acute kidney injury</title>
		<author>
			<persName><forename type="first">A</forename><surname>Dewitte</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Coquin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Meyssignac</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Crit Care</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page">R165</biblScope>
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b52">
	<monogr>
		<title level="m" type="main">Please don&apos;t call me RI anymore; I may not be the one you think I am! Crit Care</title>
		<author>
			<persName><forename type="first">N</forename><surname>Lerolle</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2012">2012</date>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page">174</biblScope>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b53">
	<analytic>
		<title level="a" type="main">Relationship between the resistive index and vascular compliance and resistance</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">O</forename><surname>Bude</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Rubin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Radiology</title>
		<imprint>
			<biblScope unit="volume">211</biblScope>
			<biblScope unit="page" from="411" to="417" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b54">
	<analytic>
		<title level="a" type="main">Understanding the Doppler RI: impact of renal arterial distensibility on the RI in a hydronephrotic ex vivo rabbit kidney model</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Murphy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Tublin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Ultrasound Med</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="page" from="303" to="314" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b55">
	<analytic>
		<title level="a" type="main">Correlation between renal vascular resistance, pulse pressure, and the resistive index in isolated perfused rabbit kidneys</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Tublin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">N</forename><surname>Tessler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Murphy</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Radiology</title>
		<imprint>
			<biblScope unit="volume">213</biblScope>
			<biblScope unit="page" from="258" to="264" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b56">
	<analytic>
		<title level="a" type="main">Intrarenal resistive index after renal transplantation</title>
		<author>
			<persName><forename type="first">M</forename><surname>Naesens</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Heylen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Lerut</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">369</biblScope>
			<biblScope unit="page" from="1797" to="1806" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b57">
	<analytic>
		<title level="a" type="main">Predicting acute kidney injury after cardiac surgery: a systematic review</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">C</forename><surname>Huen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">R</forename><surname>Parikh</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Thorac Surg</title>
		<imprint>
			<biblScope unit="volume">93</biblScope>
			<biblScope unit="page" from="337" to="347" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b58">
	<analytic>
		<title level="a" type="main">Development and validation of an acute kidney injury risk index for patients undergoing general surgery: results from a national data set</title>
		<author>
			<persName><forename type="first">S</forename><surname>Kheterpal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">K</forename><surname>Tremper</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Heung</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Anesthesiology</title>
		<imprint>
			<biblScope unit="volume">110</biblScope>
			<biblScope unit="page" from="505" to="515" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b59">
	<analytic>
		<title level="a" type="main">An overview of drug-induced acute kidney injury</title>
		<author>
			<persName><forename type="first">N</forename><surname>Pannu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">K</forename><surname>Nadim</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Crit Care Med</title>
		<imprint>
			<biblScope unit="volume">36</biblScope>
			<biblScope unit="page" from="5216" to="5223" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
	<note>Suppl</note>
</biblStruct>

<biblStruct xml:id="b60">
	<analytic>
		<title level="a" type="main">Drug-induced acute kidney injury in the critically ill adult: recognition and preventive strategies</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Bentley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">I</forename><surname>Corwin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Dasta</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Crit Care Med</title>
		<imprint>
			<biblScope unit="volume">38</biblScope>
			<biblScope unit="page" from="5169" to="5174" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note>Suppl. 6</note>
</biblStruct>

<biblStruct xml:id="b61">
	<analytic>
		<title level="a" type="main">Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: the CRISTAL randomized trial</title>
		<author>
			<persName><forename type="first">D</forename><surname>Annane</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Siami</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Jaber</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">JAMA</title>
		<imprint>
			<biblScope unit="volume">310</biblScope>
			<biblScope unit="page" from="1809" to="1817" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b62">
	<analytic>
		<title level="a" type="main">Hydroxyethyl starch or saline for fluid resuscitation in intensive care</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Myburgh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Finfer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Bellomo</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">367</biblScope>
			<biblScope unit="page" from="1901" to="1911" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b63">
	<analytic>
		<title level="a" type="main">Hydroxyethyl starch 130/0.38-0.45 versus crystalloid or albumin in patients with sepsis: systematic review with meta-analysis and trial sequential analysis</title>
		<author>
			<persName><forename type="first">N</forename><surname>Haase</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Perner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">I</forename><surname>Hennings</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">BMJ</title>
		<imprint>
			<biblScope unit="volume">346</biblScope>
			<biblScope unit="page">839</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b64">
	<analytic>
		<title level="a" type="main">Hydroxyethyl starch 130/0.42 versus Ringer&apos;s acetate in severe sepsis</title>
		<author>
			<persName><forename type="first">A</forename><surname>Perner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Haase</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">B</forename><surname>Guttormsen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">367</biblScope>
			<biblScope unit="page" from="124" to="134" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b65">
	<analytic>
		<title level="a" type="main">Association of hydroxyethyl starch administration with mortality and acute kidney injury in critically ill patients requiring volume resuscitation: a systematic review and meta-analysis</title>
		<author>
			<persName><forename type="first">R</forename><surname>Zarychanski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Abou-Setta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">F</forename><surname>Turgeon</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">JAMA</title>
		<imprint>
			<biblScope unit="volume">309</biblScope>
			<biblScope unit="page" from="678" to="688" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b66">
	<analytic>
		<title level="a" type="main">Assessment of hemodynamic efficacy and safety of 6 % hydroxyethylstarch 130/0.4 vs. 0.9 % NaCl fluid replacement in patients with severe sepsis: the CRYSTMAS study</title>
		<author>
			<persName><forename type="first">B</forename><surname>Guidet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Martinet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Boulain</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Crit Care</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page">R94</biblScope>
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b67">
	<analytic>
		<title level="a" type="main">Randomised trials of 6% tetrastarch (hydroxyethyl starch 130/0.4 or 0.42) for severe sepsis reporting mortality: systematic review and meta-analysis</title>
		<author>
			<persName><forename type="first">A</forename><surname>Patel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Waheed</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Brett</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Intensive Care Med</title>
		<imprint>
			<biblScope unit="volume">39</biblScope>
			<biblScope unit="page" from="811" to="822" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b68">
	<analytic>
		<title level="a" type="main">CRYSTMAS study adds to concerns about renal safety and increased mortality in sepsis patients</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">S</forename><surname>Hartog</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Reinhart</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Crit Care</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page">454</biblScope>
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b69">
	<analytic>
		<title level="a" type="main">Intensive insulin therapy and pentastarch resuscitation in severe sepsis</title>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">M</forename><surname>Brunkhorst</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Bloos</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">358</biblScope>
			<biblScope unit="page" from="125" to="139" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b70">
	<analytic>
		<title level="a" type="main">Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: a multicentre randomised study</title>
		<author>
			<persName><forename type="first">F</forename><surname>Schortgen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Lacherade</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Bruneel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">357</biblScope>
			<biblScope unit="page" from="911" to="916" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b71">
	<analytic>
		<title level="a" type="main">Colloids versus crystalloids for fluid resuscitation in critically ill patients</title>
		<author>
			<persName><forename type="first">P</forename><surname>Perel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Roberts</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Ker</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cochrane Database Syst Rev</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page">D000567</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b72">
	<analytic>
		<title level="a" type="main">Hydroxyethyl starch (HES) versus other fluid therapies: effects on kidney function</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">C</forename><surname>Mutter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Ruth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">B</forename><surname>Dart</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cochrane Database Syst Rev</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page">D007594</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b73">
	<analytic>
		<title level="a" type="main">Effect of waxy maize-derived hydroxyethyl starch 130/0.4 on renal function in surgical patients</title>
		<author>
			<persName><forename type="first">C</forename><surname>Martin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Jacob</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Vicaut</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Anesthesiology</title>
		<imprint>
			<biblScope unit="volume">118</biblScope>
			<biblScope unit="page" from="387" to="394" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b74">
	<monogr>
		<title level="m" type="main">The European Medicines Agency&apos;s Pharmacovigilance Risk Assessment Committee. Hydroxyethyl-starch solutions (HES) should no longer be used in patients with sepsis or burn injuries or in critically ill patients</title>
		<ptr target="http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/referrals/Hydroxyethyl_starch-containing_solu-tions/human_referral_prac_000012.jsp&amp;mid=WC0b01ac05805c516f.Accessed27" />
		<imprint>
			<date type="published" when="2015-01">2015. Jan 2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b75">
	<analytic>
		<title level="a" type="main">Dietary chloride as a determinant of &quot;sodiumdependent&quot; hypertension</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">W</forename><surname>Kurtz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">C</forename><surname>Morris</surname><genName>Jr</genName></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="volume">222</biblScope>
			<biblScope unit="page" from="1139" to="1141" />
			<date type="published" when="1983">1983</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b76">
	<analytic>
		<title level="a" type="main">Regulation of renal blood flow by plasma chloride</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">S</forename><surname>Wilcox</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Invest</title>
		<imprint>
			<biblScope unit="volume">71</biblScope>
			<biblScope unit="page" from="726" to="735" />
			<date type="published" when="1983">1983</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b77">
	<analytic>
		<title level="a" type="main">Chloride regulates afferent arteriolar contraction in response to depolarization</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">B</forename><surname>Hansen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">L</forename><surname>Jensen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Skott</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hypertension</title>
		<imprint>
			<biblScope unit="volume">32</biblScope>
			<biblScope unit="page" from="1066" to="1070" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b78">
	<analytic>
		<title level="a" type="main">A randomized, controlled, double-blind crossover study on the effects of 2-L infusions of 0.9% saline and plasma-lyte ® 148 on renal blood flow velocity and renal cortical tissue perfusion in healthy volunteers</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">H</forename><surname>Chowdhury</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">F</forename><surname>Cox</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">T</forename><surname>Francis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">N</forename><surname>Lobo</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Surg</title>
		<imprint>
			<biblScope unit="volume">256</biblScope>
			<biblScope unit="page" from="18" to="24" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b79">
	<analytic>
		<title level="a" type="main">Should chloride-rich crystalloids remain the mainstay of fluid resuscitation to prevent &apos;pre-renal&apos; acute kidney injury?:con</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">N</forename><surname>Lobo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Awad</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Kidney Int</title>
		<imprint>
			<biblScope unit="volume">86</biblScope>
			<biblScope unit="page" from="1096" to="1105" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b80">
	<analytic>
		<title level="a" type="main">The biochemical effects of restricting chloride-rich fluids in intensive care</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">M</forename><surname>Yunos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">B</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Bellomo</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Crit Care Med</title>
		<imprint>
			<biblScope unit="volume">39</biblScope>
			<biblScope unit="page" from="2419" to="2424" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b81">
	<analytic>
		<title level="a" type="main">Major complications, mortality, and resource utilization after open abdominal surgery: 0.9 % saline compared to plasma-lyte</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">D</forename><surname>Shaw</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Bagshaw</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">L</forename><surname>Goldstein</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Surg</title>
		<imprint>
			<biblScope unit="volume">255</biblScope>
			<biblScope unit="page" from="821" to="829" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b82">
	<analytic>
		<title level="a" type="main">Association between a chloride-liberal vs chloride-restrictive intravenous fluid administration strategy and kidney injury in critically ill adults</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">M</forename><surname>Yunos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Bellomo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Hegarty</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Story</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Ho</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Bailey</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">JAMA</title>
		<imprint>
			<biblScope unit="volume">308</biblScope>
			<biblScope unit="page" from="1566" to="1572" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b83">
	<analytic>
		<title level="a" type="main">Hyperchloremia after non cardiac surgery is independently associated with increased morbidity and mortality: a propensitymatched cohort study</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Mccluskey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Karkouti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Wijeysundera</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Minkovich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Tait</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Scott</forename><surname>Beattie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Anesth Analg</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page" from="412" to="421" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b84">
	<analytic>
		<title level="a" type="main">Association between the choice of IV crystalloid and in-hospital mortality among critically ill adults with sepsis</title>
		<author>
			<persName><forename type="first">K</forename><surname>Raghunathan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Shaw</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Nathanson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Crit Care Med</title>
		<imprint>
			<biblScope unit="volume">40</biblScope>
			<biblScope unit="page" from="1897" to="1905" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b85">
	<analytic>
		<title level="a" type="main">Meta-analysis of high-versus low-chloride content in perioperative and critical care fluid resuscitation</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Krajewski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Raghunathan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Paluszkiewicz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">R</forename><surname>Schermer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">D</forename><surname>Shaw</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Br J Surg</title>
		<imprint>
			<biblScope unit="volume">102</biblScope>
			<biblScope unit="page" from="24" to="36" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b86">
	<analytic>
		<title level="a" type="main">Choice of fluid in acute illness: what should be given? An international consensus</title>
		<author>
			<persName><forename type="first">K</forename><surname>Raghunathan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">T</forename><surname>Murray</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">S</forename><surname>Beattie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Adqi</forename><surname>Xii Investigators</surname></persName>
		</author>
		<author>
			<persName><surname>Group</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Br J Anaesth</title>
		<imprint>
			<biblScope unit="volume">113</biblScope>
			<biblScope unit="page" from="772" to="783" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b87">
	<analytic>
		<title level="a" type="main">Hemodynamic monitoring in shock and implications for management</title>
		<author>
			<persName><forename type="first">M</forename><surname>Antonelli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Levy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Andrews</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Intensive Care Med</title>
		<imprint>
			<biblScope unit="volume">33</biblScope>
			<biblScope unit="page" from="575" to="590" />
			<date type="published" when="2006-04">April 2006. 2007</date>
		</imprint>
	</monogr>
	<note>International consensus conference</note>
</biblStruct>

<biblStruct xml:id="b88">
	<analytic>
		<title level="a" type="main">Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">P</forename><surname>Dellinger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Levy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Rhodes</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Intensive Care Med</title>
		<imprint>
			<biblScope unit="volume">39</biblScope>
			<biblScope unit="page" from="165" to="228" />
			<date type="published" when="2012">2012. 2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b89">
	<analytic>
		<title level="a" type="main">Hemodynamic variables related to outcome in septic shock</title>
		<author>
			<persName><forename type="first">M</forename><surname>Varpula</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Tallgren</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Saukkonen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">M</forename><surname>Voipio-Pulkki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Pettila</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Intensive Care Med</title>
		<imprint>
			<biblScope unit="volume">31</biblScope>
			<biblScope unit="page" from="1066" to="1071" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b90">
	<analytic>
		<title level="a" type="main">Early goal-directed therapy in the treatment of severe sepsis and septic shock</title>
		<author>
			<persName><forename type="first">E</forename><surname>Rivers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Nguyen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Havstad</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">345</biblScope>
			<biblScope unit="page" from="1368" to="1377" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b91">
	<analytic>
		<title level="a" type="main">Hemodynamic variables and progression of acute kidney injury in critically ill patients with severe sepsis: data from the prospective observational FINNAKI study</title>
		<author>
			<persName><forename type="first">M</forename><surname>Poukkanen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Wilkman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">T</forename><surname>Vaara</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Crit Care</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page">R295</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b92">
	<analytic>
		<title level="a" type="main">High versus Low blood-pressure target in patients with septic shock</title>
		<author>
			<persName><forename type="first">P</forename><surname>Asfar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Meziani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">F</forename><surname>Hamel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">370</biblScope>
			<biblScope unit="page" from="1583" to="1593" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b93">
	<analytic>
		<title level="a" type="main">Increasing mean arterial pressure in patients with septic shock: effects on oxygen variables and renal function</title>
		<author>
			<persName><forename type="first">A</forename><surname>Bourgoin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Leone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Delmas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Garnier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Albanese</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Martin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Crit Care Med</title>
		<imprint>
			<biblScope unit="volume">33</biblScope>
			<biblScope unit="page" from="780" to="786" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b94">
	<analytic>
		<title level="a" type="main">Effects of perfusion pressure on tissue perfusion in septic shock</title>
		<author>
			<persName><forename type="first">D</forename><surname>Ledoux</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Astiz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Carpati</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">C</forename><surname>Rackow</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Crit Care Med</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="page" from="2729" to="2732" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b95">
	<analytic>
		<title level="a" type="main">Arterial blood pressure during early sepsis and outcome</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">W</forename><surname>Dunser</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Takala</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Ulmer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Intensive Care Med</title>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="page" from="1225" to="1233" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b96">
	<analytic>
		<title level="a" type="main">Diastolic arterial blood pressure: a reliable early predictor of survival in human septic shock</title>
		<author>
			<persName><forename type="first">S</forename><surname>Benchekroune</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">C</forename><surname>Karpati</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Berton</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Trauma</title>
		<imprint>
			<biblScope unit="volume">64</biblScope>
			<biblScope unit="page" from="1188" to="1195" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b97">
	<analytic>
		<title level="a" type="main">Association between systemic hemodynamics and septic acute kidney injury in critically ill patients: a retrospective observational study</title>
		<author>
			<persName><forename type="first">M</forename><surname>Legrand</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Dupuis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Simon</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Crit Care</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page">R278</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b98">
	<analytic>
		<title level="a" type="main">Relationship between intraoperative mean arterial pressure and clinical outcomes after noncardiac surgery: toward an empirical definition of hypotension</title>
		<author>
			<persName><forename type="first">M</forename><surname>Walsh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Devereaux</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">X</forename><surname>Garg</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Anesthesiology</title>
		<imprint>
			<biblScope unit="volume">119</biblScope>
			<biblScope unit="page" from="507" to="515" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b99">
	<analytic>
		<title level="a" type="main">Effect of mean arterial pressure, haemoglobin and blood transfusion during cardiopulmonary bypass on post-operative acute kidney injury</title>
		<author>
			<persName><forename type="first">M</forename><surname>Haase</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Bellomo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Story</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nephrol Dial Transplant</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="page" from="153" to="160" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b100">
	<analytic>
		<title level="a" type="main">Difference between pre-operative and cardiopulmonary bypass mean arterial pressure is independently associated with early cardiac surgery-associated acute kidney injury</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">D</forename><surname>Kanji</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Schulze</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Hervas-Malo</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Cardiothorac Surg</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page">71</biblScope>
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b101">
	<analytic>
		<title level="a" type="main">Does perioperative hemodynamic optimization protect renal function in surgical patients? A metaanalytic study</title>
		<author>
			<persName><forename type="first">N</forename><surname>Brienza</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">T</forename><surname>Giglio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Marucci</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Fiore</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Crit Care Med</title>
		<imprint>
			<biblScope unit="volume">37</biblScope>
			<biblScope unit="page" from="2079" to="2090" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b102">
	<analytic>
		<title level="a" type="main">Perioperative increase in global blood flow to explicit defined goals and outcomes after surgery: a Cochrane systematic review</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">P</forename><surname>Grocott</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Dushianthan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Hamilton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">G</forename><surname>Mythen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Harrison</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Rowan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Br J Anaesth</title>
		<imprint>
			<biblScope unit="volume">111</biblScope>
			<biblScope unit="page" from="535" to="548" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b103">
	<analytic>
		<title level="a" type="main">Fluid accumulation, survival and recovery of kidney function in critically ill patients with acute kidney injury</title>
		<author>
			<persName><forename type="first">J</forename><surname>Bouchard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">B</forename><surname>Soroko</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">M</forename><surname>Chertow</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Kidney Int</title>
		<imprint>
			<biblScope unit="volume">76</biblScope>
			<biblScope unit="page" from="422" to="427" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b104">
	<analytic>
		<title level="a" type="main">A positive fluid balance is associated with a worse outcome in patients with acute renal failure</title>
		<author>
			<persName><forename type="first">D</forename><surname>Payen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">C</forename><surname>De Pont</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Sakr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Spies</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Reinhart</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Vincent</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Crit Care</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page">R74</biblScope>
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b105">
	<analytic>
		<title level="a" type="main">Fluid balance and urine volume are independent predictors of mortality in acute kidney injury</title>
		<author>
			<persName><forename type="first">C</forename><surname>Teixeira</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Garzotto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Piccinni</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Crit Care</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page">R14</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b106">
	<analytic>
		<title level="a" type="main">Fluid balance, diuretic use, and mortality in acute kidney injury</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Grams</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Estrella</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Coresh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">G</forename><surname>Brower</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">D</forename><surname>Liu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin J Am Soc Nephrol</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page" from="966" to="973" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b107">
	<analytic>
		<title level="a" type="main">An observational study fluid balance and patient outcomes in the randomized evaluation of normal vs. augmented level of replacement therapy trial</title>
		<author>
			<persName><forename type="first">R</forename><surname>Bellomo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Cass</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Cole</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Crit Care Med</title>
		<imprint>
			<biblScope unit="volume">40</biblScope>
			<biblScope unit="page" from="1753" to="1760" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b108">
	<analytic>
		<title level="a" type="main">Perioperative fluid restriction in major abdominal surgery: systematic review and meta-analysis of randomized, clinical trials</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Boland</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Noorani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Varty</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Coffey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Agha</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">R</forename><surname>Walsh</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">World J Surg</title>
		<imprint>
			<biblScope unit="volume">37</biblScope>
			<biblScope unit="page" from="1193" to="1202" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b109">
	<analytic>
		<title level="a" type="main">A meta-analysis of randomised controlled trials of intravenous fluid therapy in major elective open abdominal surgery: getting the balance right</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">K</forename><surname>Varadhan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">N</forename><surname>Lobo</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc Nutr Soc</title>
		<imprint>
			<biblScope unit="volume">69</biblScope>
			<biblScope unit="page" from="488" to="498" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b110">
	<analytic>
		<title level="a" type="main">Norepinephrine therapy has no deleterious renal effects in human septic shock</title>
		<author>
			<persName><forename type="first">P</forename><surname>Desjars</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Pinaud</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Bugnon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Tasseau</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Crit Care Med</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page" from="426" to="429" />
			<date type="published" when="1989">1989</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b111">
	<analytic>
		<title level="a" type="main">A reappraisal of norepinephrine therapy in human septic shock</title>
		<author>
			<persName><forename type="first">P</forename><surname>Desjars</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Pinaud</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Potel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Tasseau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename><surname>Touze</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Crit Care Med</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page" from="134" to="137" />
			<date type="published" when="1987">1987</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b112">
	<analytic>
		<title level="a" type="main">Effects of norepinephrine on renal function in septic patients with normal and elevated serum lactate levels</title>
		<author>
			<persName><forename type="first">T</forename><surname>Fukuoka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Nishimura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Imanaka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Taenaka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Yoshiya</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Takezawa</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Crit Care Med</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page" from="1104" to="1107" />
			<date type="published" when="1989">1989</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b113">
	<analytic>
		<title level="a" type="main">Effect of norepinephrine on the outcome of septic shock</title>
		<author>
			<persName><forename type="first">C</forename><surname>Martin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Viviand</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Leone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Thirion</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Crit Care Med</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="page" from="2758" to="2765" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b114">
	<analytic>
		<title level="a" type="main">Noradrenaline in the &quot;high output-low resistance&quot; state of patients with abdominal sepsis</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">M</forename><surname>Redl-Wenzl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Armbruster</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Edelmann</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Anaesthesist</title>
		<imprint>
			<biblScope unit="volume">39</biblScope>
			<biblScope unit="page" from="525" to="529" />
			<date type="published" when="1990">1990</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b115">
	<analytic>
		<title level="a" type="main">Renal effects of norepinephrine in septic and nonseptic patients</title>
		<author>
			<persName><forename type="first">J</forename><surname>Albanese</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Leone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Garnier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Bourgoin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Antonini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Martin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Chest</title>
		<imprint>
			<biblScope unit="volume">126</biblScope>
			<biblScope unit="page" from="534" to="539" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b116">
	<analytic>
		<title level="a" type="main">Norepinephrine or dopamine for the treatment of hyperdynamic septic shock?</title>
		<author>
			<persName><forename type="first">C</forename><surname>Martin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Papazian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Perrin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Saux</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Gouin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Chest</title>
		<imprint>
			<biblScope unit="volume">103</biblScope>
			<biblScope unit="page" from="1826" to="1831" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b117">
	<analytic>
		<title level="a" type="main">Terlipressin in catecholamine-resistant septic shock patients</title>
		<author>
			<persName><forename type="first">M</forename><surname>Leone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Albanese</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Delmas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Chaabane</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Garnier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Martin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Shock</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="page" from="314" to="319" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b118">
	<analytic>
		<title level="a" type="main">Terlipressin or norepinephrine in hyperdynamic septic shock: a prospective, randomized study</title>
		<author>
			<persName><forename type="first">J</forename><surname>Albanese</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Leone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Delmas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Martin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Crit Care Med</title>
		<imprint>
			<biblScope unit="volume">33</biblScope>
			<biblScope unit="page" from="1897" to="1902" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b119">
	<analytic>
		<title level="a" type="main">Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">S</forename><surname>Rihal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">C</forename><surname>Textor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">E</forename><surname>Grill</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Circulation</title>
		<imprint>
			<biblScope unit="volume">105</biblScope>
			<biblScope unit="page" from="2259" to="2264" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b120">
	<analytic>
		<title level="a" type="main">Contrast-induced nephropathy: is the picture any clearer?</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Rudnick</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Goldfarb</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Tumlin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin J Am Soc Nephrol</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page" from="261" to="262" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b121">
	<analytic>
		<title level="a" type="main">Epidemiology of contrast-associated acute kidney injury in ICU patients: a retrospective cohort analysis</title>
		<author>
			<persName><forename type="first">Eaj</forename><surname>Hoste</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Doom</surname></persName>
		</author>
		<author>
			<persName><forename type="first">De</forename><surname>Waele</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Intensive Care Med</title>
		<imprint>
			<biblScope unit="volume">37</biblScope>
			<biblScope unit="page" from="1921" to="1931" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b122">
	<analytic>
		<title level="a" type="main">Prevention of contrast-induced nephropathy by N-acetylcysteine in critically ill patients: different definitions, different results</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">G</forename><surname>Chousterman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Bouadma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Moutereau</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Crit Care</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page" from="701" to="709" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b123">
	<analytic>
		<title level="a" type="main">Accuracy of plasma neutrophil gelatinase-associated lipocalin in the early diagnosis of contrastinduced acute kidney injury in critical illness</title>
		<author>
			<persName><forename type="first">X</forename><surname>Valette</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Savary</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Nowoczyn</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Intensive Care Med</title>
		<imprint>
			<biblScope unit="volume">39</biblScope>
			<biblScope unit="page" from="857" to="865" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b124">
	<analytic>
		<title level="a" type="main">Incidence and outcome of contrast-associated acute kidney injury in a mixed medical-surgical ICU population: a retrospective study</title>
		<author>
			<persName><surname>Clec'h C</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Razafimandimby</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Laouisset</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">BMC Nephrol</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page" from="14" to="31" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b125">
	<analytic>
		<title level="a" type="main">Sodium bicarbonate for the prevention of contrast induced-acute kidney injury: a systematic review and meta-analysis</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">S</forename><surname>Brar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Hiremath</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Dangas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin J Am Soc Nephrol</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page" from="1584" to="1592" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b126">
	<analytic>
		<title level="a" type="main">Systematic review: sodium bicarbonate treatment regimens for the prevention of contrast-induced nephropathy</title>
		<author>
			<persName><forename type="first">S</forename><surname>Zoungas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Ninomiya</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Huxley</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Intern Med</title>
		<imprint>
			<biblScope unit="volume">151</biblScope>
			<biblScope unit="page" from="631" to="638" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b127">
	<analytic>
		<title level="a" type="main">Sodium bicarbonate plus N-acetylcysteine prophylaxis: a meta-analysis</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Brown</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Block</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Malenka</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">JAAC Cardiovasc Interv</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page" from="1116" to="1124" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b128">
	<analytic>
		<title level="a" type="main">Intravenous N-acetylcysteine for prevention of contrast-induced nephropathy: a meta-analysis of randomized, controlled trials</title>
		<author>
			<persName><forename type="first">Z</forename><surname>Sun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><surname>Fu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Cao</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS One</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page">e55124</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b129">
	<analytic>
		<title level="a" type="main">Sodium bicarbonate therapy for the prevention of contrast-induced acute kidney injury-a systematic review and meta-analysis</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Jang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">Y</forename><surname>Jin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Seo</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Circ J</title>
		<imprint>
			<biblScope unit="volume">76</biblScope>
			<biblScope unit="page" from="2255" to="2265" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b130">
	<analytic>
		<title level="a" type="main">Effects of saline, mannitol, and furosemide to prevent acute decreases in renal function induced by radiocontrast agents</title>
		<author>
			<persName><forename type="first">R</forename><surname>Solomon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Werner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Mann</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">331</biblScope>
			<biblScope unit="page" from="1416" to="1420" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b131">
	<analytic>
		<title level="a" type="main">N-acetylcysteine in the prevention of contrastinduced nephropathy: publication bias perpetuated by meta-analyses</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">T</forename><surname>Vaitkus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Brar</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am Heart J</title>
		<imprint>
			<biblScope unit="volume">153</biblScope>
			<biblScope unit="page" from="275" to="280" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b132">
	<analytic>
		<title level="a" type="main">Sodium bicarbonate for prevention of contrast-induced acute kidney injury: a systematic review and meta-analysis</title>
		<author>
			<persName><forename type="first">Eaj</forename><surname>Hoste</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>De Waele</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Gevaert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Uchino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Kellum</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nephrol Dial Transplant</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="page" from="747" to="758" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b133">
	<analytic>
		<title level="a" type="main">Sodium chloride vs. sodium bicarbonate for the prevention of contrast medium-induced nephropathy: a randomized controlled trial</title>
		<author>
			<persName><forename type="first">T</forename><surname>Klima</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Christ</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Marana</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur Heart J</title>
		<imprint>
			<biblScope unit="volume">33</biblScope>
			<biblScope unit="page" from="2071" to="2079" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b134">
	<analytic>
		<title level="a" type="main">A randomized comparison of 1-h sodium bicarbonate hydration versus standard peri-procedural saline hydration in patients with chronic kidney disease undergoing intravenous contrast-enhanced computerized tomography</title>
		<author>
			<persName><forename type="first">J</forename><surname>Kooiman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Ywj</forename><surname>Sijpkens</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J-Ppm</forename><surname>De Vries</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nephrol Dial Transplant</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="page" from="1029" to="1036" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b135">
	<analytic>
		<title level="a" type="main">Pharmacological strategies to prevent contrast-induced acute kidney injury</title>
		<author>
			<persName><forename type="first">P</forename><surname>Pattharanitima</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Tasanarong</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">BioMed Res Int</title>
		<imprint>
			<biblScope unit="page">236930</biblScope>
			<date type="published" when="2014">2014. 2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b136">
	<analytic>
		<title level="a" type="main">Meta-analysis: effectiveness of drugs for preventing contrast-induced nephropathy</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Kelly</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Dwamena</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Cronin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Intern Med</title>
		<imprint>
			<biblScope unit="volume">148</biblScope>
			<biblScope unit="page" from="284" to="294" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b137">
	<analytic>
		<title level="a" type="main">Radiocontrast-induced acute kidney injury</title>
		<author>
			<persName><forename type="first">P</forename><surname>Mccullough</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nephron Physiol</title>
		<imprint>
			<biblScope unit="volume">109</biblScope>
			<biblScope unit="page" from="61" to="72" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b138">
	<analytic>
		<title level="a" type="main">Acute renal failure</title>
		<author>
			<persName><forename type="first">J</forename><surname>Kellum</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Leblanc</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Venkataraman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">BMJ Clin Evid</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<date type="published" when="2001">2008. 2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b139">
	<analytic>
		<title level="a" type="main">Prospective evaluation of the effect of an aminoglycoside dosing regimen on rates of observed nephrotoxicity and ototoxicity</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Rybak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">J</forename><surname>Abate</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">L</forename><surname>Kang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Antimicrob Agents Chemother</title>
		<imprint>
			<biblScope unit="volume">43</biblScope>
			<biblScope unit="page" from="1549" to="1555" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b140">
	<analytic>
		<title level="a" type="main">A meta-analysis of extendedinterval dosing versus multiple daily dosing of aminoglycosides</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">C</forename><surname>Bailey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Little</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Littenberg</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Infect Dis</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="page" from="786" to="795" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b141">
	<analytic>
		<title level="a" type="main">Once-daily aminoglycoside dosing in immunocompetent adults: a meta-analysis</title>
		<author>
			<persName><forename type="first">R</forename><surname>Hatala</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Dinh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Cook</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Intern Med</title>
		<imprint>
			<biblScope unit="volume">124</biblScope>
			<biblScope unit="page" from="717" to="725" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b142">
	<analytic>
		<title level="a" type="main">Aminoglycoside-induced nephrotoxicity</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">A</forename><surname>Wargo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Edwards</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Pharm Pract</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="page" from="573" to="577" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b143">
	<analytic>
		<title level="a" type="main">Propensity-based study of aminoglycoside nephrotoxicity in patients with severe sepsis or septic shock</title>
		<author>
			<persName><forename type="first">W</forename><surname>Picard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Bazin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Clouzeau</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Antimicrob Agents Chemother</title>
		<imprint>
			<biblScope unit="volume">58</biblScope>
			<biblScope unit="page" from="7468" to="7474" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b144">
	<analytic>
		<title level="a" type="main">Aminoglycosides in septic shock: an overview, with specific consideration given to their nephrotoxic risk</title>
		<author>
			<persName><forename type="first">A</forename><surname>Boyer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Gruson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Bouchet</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Drug Saf</title>
		<imprint>
			<biblScope unit="volume">36</biblScope>
			<biblScope unit="page" from="217" to="230" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b145">
	<analytic>
		<title level="a" type="main">Efficacy, nephrotoxicity and ototoxicity of aminoglycosides, mathematically modelled for modellingsupported therapeutic drug monitoring</title>
		<author>
			<persName><forename type="first">S</forename><surname>Croes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">H</forename><surname>Koop</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Van Gils</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Neef</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur J Pharm</title>
		<imprint>
			<biblScope unit="volume">45</biblScope>
			<biblScope unit="page" from="90" to="100" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b146">
	<analytic>
		<title level="a" type="main">Pharmacological considerations for the proper clinical use of aminoglycosides</title>
		<author>
			<persName><forename type="first">S</forename><surname>Pagkalis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Mantadakis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">N</forename><surname>Mavros</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Drugs</title>
		<imprint>
			<biblScope unit="volume">71</biblScope>
			<biblScope unit="page" from="2277" to="2294" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b147">
	<analytic>
		<title level="a" type="main">Prevalence and risk factors for aminoglycoside nephrotoxicity in intensive care units</title>
		<author>
			<persName><forename type="first">Jfp</forename><surname>Oliveira</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Silva</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">D</forename><surname>Barbieri</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Antimicrob Agents Chemother</title>
		<imprint>
			<biblScope unit="volume">53</biblScope>
			<biblScope unit="page" from="2887" to="2891" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b148">
	<analytic>
		<title level="a" type="main">Gentamicin-associated acute kidney injury</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">M</forename><surname>Selby</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Shaw</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Woodier</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">QJM</title>
		<imprint>
			<biblScope unit="volume">102</biblScope>
			<biblScope unit="page" from="873" to="880" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b149">
	<analytic>
		<title level="a" type="main">Pharmacokinetic dosing of aminoglycosides: a controlled trial</title>
		<author>
			<persName><forename type="first">C</forename><surname>Bartal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Danon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Schlaeffer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Med</title>
		<imprint>
			<biblScope unit="volume">114</biblScope>
			<biblScope unit="page" from="194" to="198" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b150">
	<analytic>
		<title level="a" type="main">Drug use and nephrotoxicity in the intensive care unit</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Perazella</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Kidney Int</title>
		<imprint>
			<biblScope unit="volume">81</biblScope>
			<biblScope unit="page" from="1172" to="1178" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b151">
	<analytic>
		<title level="a" type="main">Common drug interactions leading to adverse drug events in the intensive care unit: management and pharmacokinetic considerations</title>
		<author>
			<persName><forename type="first">J</forename><surname>Papadopoulos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">L</forename><surname>Smithburger</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Crit Care Med</title>
		<imprint>
			<biblScope unit="volume">38</biblScope>
			<biblScope unit="page" from="S126" to="135" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b152">
	<analytic>
		<title level="a" type="main">Drug-induced acute kidney injury</title>
		<author>
			<persName><forename type="first">M</forename><surname>Schetz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Dasta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Goldstein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Golper</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Curr Opin Crit Care</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="555" to="565" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b153">
	<analytic>
		<title level="a" type="main">Benefits and risks of furosemide in acute kidney injury</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">M</forename><surname>Ho</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">M</forename><surname>Power</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Anaesthesia</title>
		<imprint>
			<biblScope unit="volume">63</biblScope>
			<biblScope unit="page" from="283" to="294" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b154">
	<analytic>
		<title level="a" type="main">Meta-analysis of frusemide to prevent or treat acute renal failure</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">M</forename><surname>Ho</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Sheridan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">BMJ</title>
		<imprint>
			<biblScope unit="volume">333</biblScope>
			<biblScope unit="page">420</biblScope>
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b155">
	<analytic>
		<title level="a" type="main">Prophylactic perioperative sodium bicarbonate to prevent acute kidney injury following open heart surgery: a multicenter double-blinded randomized controlled trial</title>
		<author>
			<persName><forename type="first">M</forename><surname>Haase</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">H</forename><surname>Fielitz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Plass</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS One</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page">e1001426</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b156">
	<analytic>
		<title level="a" type="main">Lack of effectiveness of sodium bicarbonate in preventing kidney injury in patients undergoing cardiac surgery: a randomized controlled trial</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Kristeller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">S</forename><surname>Zavorsky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Prior</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Pharmacotherapy</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page" from="710" to="717" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b157">
	<analytic>
		<title level="a" type="main">Sodium bicarbonate infusion to reduce cardiac surgery-associated acute kidney injury: a phase II multicenter double-blind randomized controlled trial</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">P</forename><surname>Mcguinness</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Parke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Bellomo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Fmp</forename><surname>Van Haren</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Bailey</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Crit Care Med</title>
		<imprint>
			<biblScope unit="volume">41</biblScope>
			<biblScope unit="page" from="1599" to="1607" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b158">
	<analytic>
		<title level="a" type="main">Sodium bicarbonate supplements for treating acute kidney injury</title>
		<author>
			<persName><forename type="first">J</forename><surname>Hewitt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Uniacke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">K</forename><surname>Hansi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Venkat-Raman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Mccarthy</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cochrane Database Syst Rev</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page">D009204</biblScope>
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b159">
	<analytic>
		<title level="a" type="main">Rhabdomyolysis and acute kidney injury</title>
		<author>
			<persName><forename type="first">X</forename><surname>Bosch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Poch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Grau</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">361</biblScope>
			<biblScope unit="page" from="62" to="72" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b160">
	<analytic>
		<title level="a" type="main">The syndrome of rhabdomyolysis: complications and treatment</title>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">S</forename><surname>Chatzizisis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Misirli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">I</forename><surname>Hatzitolios</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">D</forename><surname>Giannoglou</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur J Intern Med</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="page" from="568" to="574" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b161">
	<analytic>
		<title level="a" type="main">Prevention of kidney injury following rhabdomyolysis: a systematic review</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">J</forename><surname>Scharman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">G</forename><surname>Troutman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Pharmacother</title>
		<imprint>
			<biblScope unit="volume">47</biblScope>
			<biblScope unit="page" from="90" to="105" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b162">
	<analytic>
		<title level="a" type="main">Fluid resuscitation and systemic complications in crush syndrome: 14 Hanshin-Awaji earthquake patients</title>
		<author>
			<persName><forename type="first">T</forename><surname>Shimazu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Yoshioka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Nakata</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Trauma</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="page" from="641" to="646" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b163">
	<analytic>
		<title level="a" type="main">Early and vigorous fluid resuscitation prevents acute renal failure in the crush victims of catastrophic earthquakes</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">I</forename><surname>Gunal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Celiker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Dogukan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Am Soc Nephrol</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page" from="1862" to="1867" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b164">
	<analytic>
		<title level="a" type="main">Prophylaxis of acute renal failure in patients with rhabdomyolysis</title>
		<author>
			<persName><forename type="first">E</forename><surname>Homsi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">F</forename><surname>Barreiro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Orlando</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">M</forename><surname>Higa</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ren Fail</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="page" from="283" to="288" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b165">
	<analytic>
		<title level="a" type="main">Preventing renal failure in patients with rhabdomyolysis: do bicarbonate and mannitol make a difference?</title>
		<author>
			<persName><forename type="first">Cvr</forename><surname>Brown</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Rhee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Chan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Evans</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Demetriades</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">C</forename><surname>Velmahos</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Trauma</title>
		<imprint>
			<biblScope unit="volume">56</biblScope>
			<biblScope unit="page" from="1191" to="1196" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b166">
	<analytic>
		<title level="a" type="main">Comparison of lactated Ringer&apos;s solution and 0.9% saline in the treatment of rhabdomyolysis induced by doxylamine intoxication</title>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">S</forename><surname>Cho</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Lim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">H</forename><surname>Kim</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Emerg Med J</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="page" from="276" to="280" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b167">
	<analytic>
		<title level="a" type="main">The effect of mannitol on renal function following cardio-pulmonary bypass in patients with normal pre-operative creatinine</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">G</forename><surname>Yallop</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">V</forename><surname>Sheppard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">C</forename><surname>Smith</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Anaesthesia</title>
		<imprint>
			<biblScope unit="volume">63</biblScope>
			<biblScope unit="page" from="576" to="582" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b168">
	<analytic>
		<title level="a" type="main">The effect of mannitol on renal function after cardiopulmonary bypass in patients with established renal dysfunction</title>
		<author>
			<persName><forename type="first">Mna</forename><surname>Smith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Best</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">V</forename><surname>Sheppard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">C</forename><surname>Smith</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Anaesthesia</title>
		<imprint>
			<biblScope unit="volume">63</biblScope>
			<biblScope unit="page" from="701" to="704" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b169">
	<analytic>
		<title level="a" type="main">Forced euvolemic diuresis with mannitol and furosemide for prevention of contrast-induced nephropathy in patients with CKD undergoing coronary angiography: a randomized controlled trial</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">R</forename><surname>Majumdar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Kjellstrand</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">J</forename><surname>Tymchak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Hervas-Malo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Taylor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">K</forename><surname>Teo</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Kidney Dis</title>
		<imprint>
			<biblScope unit="volume">54</biblScope>
			<biblScope unit="page" from="602" to="609" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b170">
	<analytic>
		<title level="a" type="main">Meta-analysis: low-dose dopamine increases urine output but does not prevent renal dysfunction or death</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">O</forename><surname>Friedrich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Adhikari</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Herridge</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Beyene</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Intern Med</title>
		<imprint>
			<biblScope unit="volume">142</biblScope>
			<biblScope unit="page" from="510" to="524" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b171">
	<analytic>
		<title level="a" type="main">Use of dopamine in acute renal failure: a metaanalysis</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Kellum</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Decker</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Crit Care Med</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="page" from="1526" to="1531" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b172">
	<analytic>
		<title level="a" type="main">Low-dose dopamine in patients with early renal dysfunction: a placebo-controlled randomised trial. Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group</title>
		<author>
			<persName><forename type="first">R</forename><surname>Bellomo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Chapman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Finfer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Hickling</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Myburgh</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">356</biblScope>
			<biblScope unit="page" from="2139" to="2143" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b173">
	<analytic>
		<title level="a" type="main">Fenoldopam mesylate for the prevention of contrast-induced nephropathy: a randomized controlled trial</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">W</forename><surname>Stone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">A</forename><surname>Mccullough</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Tumlin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">JAMA</title>
		<imprint>
			<biblScope unit="volume">290</biblScope>
			<biblScope unit="page" from="2284" to="2291" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b174">
	<analytic>
		<title level="a" type="main">Fenoldopam for renal protection in patients undergoing cardiopulmonary bypass</title>
		<author>
			<persName><forename type="first">P-P</forename><surname>Caimmi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Pagani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Micalizzi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Cardiothorac Vasc Anesth</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page" from="491" to="494" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b175">
	<analytic>
		<title level="a" type="main">Renoprotective action of fenoldopam in high-risk patients undergoing cardiac surgery: a prospective, double-blind, randomized clinical trial</title>
		<author>
			<persName><forename type="first">T</forename><surname>Bove</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Landoni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">G</forename><surname>Calabrò</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Circulation</title>
		<imprint>
			<biblScope unit="volume">111</biblScope>
			<biblScope unit="page" from="3230" to="3235" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b176">
	<analytic>
		<title level="a" type="main">A comparison between fenoldopam and low-dose dopamine in early renal dysfunction of critically ill patients</title>
		<author>
			<persName><forename type="first">N</forename><surname>Brienza</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Malcangi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Dalfino</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Crit Care Med</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="page" from="707" to="714" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b177">
	<analytic>
		<title level="a" type="main">Fenoldopam prophylaxis of postoperative acute renal failure in high-risk cardiac surgery patients</title>
		<author>
			<persName><forename type="first">M</forename><surname>Ranucci</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Soro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Barzaghi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Thorac Surg</title>
		<imprint>
			<biblScope unit="volume">78</biblScope>
			<biblScope unit="page" from="1332" to="1337" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b178">
	<analytic>
		<title level="a" type="main">Fenoldopam mesylate in early acute tubular necrosis: a randomized, double-blind, placebo-controlled clinical trial</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Tumlin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">W</forename><surname>Finkel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">T</forename><surname>Murray</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Samuels</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Cotsonis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">D</forename><surname>Shaw</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Kidney Dis</title>
		<imprint>
			<biblScope unit="volume">46</biblScope>
			<biblScope unit="page" from="26" to="34" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b179">
	<analytic>
		<title level="a" type="main">Prophylactic fenoldopam for renal protection in sepsis: a randomized, double-blind, placebo-controlled pilot trial</title>
		<author>
			<persName><forename type="first">A</forename><surname>Morelli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Ricci</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Bellomo</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Crit Care Med</title>
		<imprint>
			<biblScope unit="volume">33</biblScope>
			<biblScope unit="page" from="2451" to="2456" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b180">
	<analytic>
		<title level="a" type="main">Pharmacological therapies for the prevention of acute kidney injury following cardiac surgery: a systematic review</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">N</forename><surname>Patel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Rogers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">D</forename><surname>Angelini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">J</forename><surname>Murphy</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Heart Fail Rev</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page" from="553" to="567" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b181">
	<analytic>
		<title level="a" type="main">Fenoldopam reduces the need for renal replacement therapy and in-hospital death in cardiovascular surgery: a meta-analysis</title>
		<author>
			<persName><forename type="first">G</forename><surname>Landoni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Ggl</forename><surname>Biondi-Zoccai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Marino</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Cardiothorac Vasc Anesth</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="page" from="27" to="33" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b182">
	<analytic>
		<title level="a" type="main">Beneficial impact of fenoldopam in critically ill patients with or at risk for acute renal failure: a meta-analysis of randomized clinical trials</title>
		<author>
			<persName><forename type="first">G</forename><surname>Landoni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Ggl</forename><surname>Biondi-Zoccai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Tumlin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Kidney Dis</title>
		<imprint>
			<biblScope unit="volume">49</biblScope>
			<biblScope unit="page" from="56" to="68" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b183">
	<analytic>
		<title level="a" type="main">Fenoldopam and acute renal failure in cardiac surgery: a meta-analysis of randomized placebocontrolled trials</title>
		<author>
			<persName><forename type="first">A</forename><surname>Zangrillo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Ggl</forename><surname>Biondi-Zoccai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Frati</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Cardiothorac Vasc Anesth</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page" from="407" to="413" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b184">
	<analytic>
		<title level="a" type="main">Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Sackner-Bernstein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">A</forename><surname>Skopicki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">D</forename><surname>Aaronson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Circulation</title>
		<imprint>
			<biblScope unit="volume">111</biblScope>
			<biblScope unit="page" from="1487" to="1491" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b185">
	<analytic>
		<title level="a" type="main">Atrial natriuretic peptide for management of acute kidney injury: a systematic review and meta-analysis</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">U</forename><surname>Nigwekar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">D</forename><surname>Navaneethan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">R</forename><surname>Parikh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">K</forename><surname>Hix</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin J Am Soc Nephrol</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page" from="261" to="272" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b186">
	<analytic>
		<title level="a" type="main">Cardiovascular and renal effects of carperitide and nesiritide in cardiovascular surgery patients: a systematic review and meta-analysis</title>
		<author>
			<persName><forename type="first">C</forename><surname>Mitaka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Kudo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Haraguchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Tomita</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Crit Care</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page">R258</biblScope>
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b187">
	<analytic>
		<title level="a" type="main">Atrial natriuretic peptide for preventing and treating acute kidney injury</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">U</forename><surname>Nigwekar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">D</forename><surname>Navaneethan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">R</forename><surname>Parikh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">K</forename><surname>Hix</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cochrane Database Syst Rev</title>
		<imprint>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page">D006028</biblScope>
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b188">
	<analytic>
		<title level="a" type="main">Efficacy of N-acetylcysteine in preventing renal injury after heart surgery: a systematic review of randomized trials</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">S</forename><surname>Adabag</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Ishani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">E</forename><surname>Bloomfield</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">K</forename><surname>Ngo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">J</forename><surname>Wilt</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur Heart J</title>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="page" from="1910" to="1917" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b189">
	<analytic>
		<title level="a" type="main">N-acetylcysteine prophylaxis significantly reduces the risk of radiocontrast-induced nephropathy: comprehensive meta-analysis</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">H</forename><surname>Duong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">A</forename><surname>Mackenzie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Malenka</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Catheter Cardiovasc Interv</title>
		<imprint>
			<biblScope unit="volume">64</biblScope>
			<biblScope unit="page" from="471" to="479" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b190">
	<analytic>
		<title level="a" type="main">Meta-analysis of N-acetylcysteine to prevent acute renal failure after major surgery</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">M</forename><surname>Ho</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Djr</forename><surname>Morgan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Kidney Dis</title>
		<imprint>
			<biblScope unit="volume">53</biblScope>
			<biblScope unit="page" from="33" to="40" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b191">
	<analytic>
		<title level="a" type="main">N-acetylcysteine in cardiovascularsurgery-associated renal failure: a meta-analysis</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">U</forename><surname>Nigwekar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Kandula</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Thorac Surg</title>
		<imprint>
			<biblScope unit="volume">87</biblScope>
			<biblScope unit="page" from="139" to="147" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b192">
	<analytic>
		<title level="a" type="main">Multicenter clinical trial of recombinant human insulin-like growth factor I in patients with acute renal failure</title>
		<author>
			<persName><forename type="first">R</forename><surname>Hirschberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Kopple</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Lipsett</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Kidney Int</title>
		<imprint>
			<biblScope unit="volume">55</biblScope>
			<biblScope unit="page" from="2423" to="2432" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b193">
	<analytic>
		<title level="a" type="main">A randomized, placebocontrolled trial of IGF-1 for delayed graft function: a human model to study postischemic ARF</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Hladunewich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Corrigan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">C</forename><surname>Derby</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Kidney Int</title>
		<imprint>
			<biblScope unit="volume">64</biblScope>
			<biblScope unit="page" from="593" to="602" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b194">
	<analytic>
		<title level="a" type="main">Early intervention with erythropoietin does not affect the outcome of acute kidney injury (the EARLYARF trial)</title>
		<author>
			<persName><forename type="first">Z</forename><forename type="middle">H</forename><surname>Endre</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Walker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename><surname>Pickering</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Kidney Int</title>
		<imprint>
			<biblScope unit="volume">77</biblScope>
			<biblScope unit="page" from="1020" to="1030" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b195">
	<analytic>
		<title level="a" type="main">Prevention of acute kidney injury by erythropoietin in patients undergoing coronary artery bypass grafting: a pilot study</title>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">R</forename><surname>Song</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>You</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Nephrol</title>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="page" from="253" to="260" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b196">
	<analytic>
		<title level="a" type="main">BG9719 (CVT-124), an A1 adenosine receptor antagonist, protects against the decline in renal function observed with diuretic therapy</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">S</forename><surname>Gottlieb</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">C</forename><surname>Brater</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Thomas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Circulation</title>
		<imprint>
			<biblScope unit="volume">105</biblScope>
			<biblScope unit="page" from="1348" to="1353" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b197">
	<analytic>
		<title level="a" type="main">CKI-201 and CKI-202 Investigators. The effects of KW-3902, an adenosine A1-receptor antagonist, on diuresis and renal function in patients with acute decompensated heart failure and renal impairment or diuretic resistance</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Givertz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">M</forename><surname>Massie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">K</forename><surname>Fields</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">L</forename><surname>Pearson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">C</forename><surname>Dittrich</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Am Coll Cardiol</title>
		<imprint>
			<biblScope unit="volume">50</biblScope>
			<biblScope unit="page" from="1551" to="1560" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b198">
	<analytic>
		<title level="a" type="main">Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">M</forename><surname>Massie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>O'connor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Metra</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">363</biblScope>
			<biblScope unit="page" from="1419" to="1428" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b199">
	<analytic>
		<title level="a" type="main">The tumor lysis syndrome</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">C</forename><surname>Howard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">P</forename><surname>Jones</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C-H</forename><surname>Pui</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">364</biblScope>
			<biblScope unit="page" from="1844" to="1854" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b200">
	<analytic>
		<title level="a" type="main">Extended duration of prehydration does not prevent nephrotoxicity or delayed drug elimination in high-dose methotrexate infusions: a prospectively randomized cross-over study</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">S</forename><surname>Mikkelsen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">D</forename><surname>Mamoudou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Tuckuviene</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">S</forename><surname>Wehner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Schroeder</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Pediatr Blood Cancer</title>
		<imprint>
			<biblScope unit="volume">61</biblScope>
			<biblScope unit="page" from="297" to="301" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b201">
	<analytic>
		<title level="a" type="main">Effect of urine pH and flow on renal clearance of methotrexate</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">E</forename><surname>Sand</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Jacobsen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur J Clin Pharmacol</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="page" from="453" to="456" />
			<date type="published" when="1981">1981</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b202">
	<analytic>
		<title level="a" type="main">Effect of hydration on methotrexate plasma concentrations in children with acute lymphocytic leukemia</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Christensen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">K</forename><surname>Rivera</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">R</forename><surname>Crom</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Hancock</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">E</forename><surname>Evans</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Oncol</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page" from="797" to="801" />
			<date type="published" when="1988">1988</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b203">
	<analytic>
		<title level="a" type="main">Effects of sodium in hydration solution on plasma methotrexate concentrations following high-dose methotrexate in children with acute lymphoblastic leukemia</title>
		<author>
			<persName><forename type="first">A</forename><surname>Kinoshita</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Kurosawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Kondoh</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Chemother Pharmacol</title>
		<imprint>
			<biblScope unit="volume">51</biblScope>
			<biblScope unit="page" from="256" to="260" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b204">
	<analytic>
		<title level="a" type="main">Patient characteristics associated with high-risk methotrexate concentrations and toxicity</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">V</forename><surname>Relling</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Fairclough</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Ayers</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Oncol</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page" from="1667" to="1672" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b205">
	<analytic>
		<title level="a" type="main">Tumour lysis syndrome and acute kidney injury in high-risk haematology patients in the rasburicase era. A prospective multicentre study from the Groupe de Recherche en Réanimation Respiratoire et Onco-Hématologique</title>
		<author>
			<persName><forename type="first">M</forename><surname>Darmon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Vincent</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Camous</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Br J Haematol</title>
		<imprint>
			<biblScope unit="volume">162</biblScope>
			<biblScope unit="page" from="489" to="497" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b206">
	<analytic>
		<title level="a" type="main">Rasburicase in the prevention of laboratory/clinical tumour lysis syndrome in children with advanced mature B-NHL: a Children&apos;s Oncology Group Report</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Galardy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Hochberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">L</forename><surname>Perkins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Harrison</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Goldman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Cairo</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Br J Haematol</title>
		<imprint>
			<biblScope unit="volume">163</biblScope>
			<biblScope unit="page" from="365" to="372" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b207">
	<analytic>
		<title level="a" type="main">A novel role for uric acid in acute kidney injury associated with tumour lysis syndrome</title>
		<author>
			<persName><forename type="first">M</forename><surname>Shimada</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Johnson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">May</forename><surname>Ws</surname><genName>Jr</genName></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nephrol Dial Transplant</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="page" from="2960" to="2964" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b208">
	<analytic>
		<title level="a" type="main">Rasburicase in tumor lysis syndrome of the adult: a systematic review and meta-analysis</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Lopez-Olivo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Pratt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">L</forename><surname>Palla</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Salahudeen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Kidney Dis</title>
		<imprint>
			<biblScope unit="volume">62</biblScope>
			<biblScope unit="page" from="481" to="492" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b209">
	<analytic>
		<title level="a" type="main">Urate oxidase for the prevention and treatment of tumor lysis syndrome in children with cancer</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">K</forename><surname>Cheuk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">K</forename><surname>Chiang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">C</forename><surname>Chan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">Y</forename><surname>Ha</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cochrane Database Syst Rev</title>
		<imprint>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page">D006945</biblScope>
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b210">
	<analytic>
		<title level="a" type="main">Control of plasma uric acid in adults at risk for tumor Lysis syndrome: efficacy and safety of rasburicase alone and rasburicase followed by allopurinol compared with allopurinol alone-results of a multicenter phase III study</title>
		<author>
			<persName><forename type="first">J</forename><surname>Cortes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">O</forename><surname>Moore</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">T</forename><surname>Maziarz</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Oncol</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="page" from="4207" to="4213" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b211">
	<analytic>
		<title level="a" type="main">A randomized comparison between rasburicase and allopurinol in children with lymphoma or leukemia at high risk for tumor lysis</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">C</forename><surname>Goldman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Holcenberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">Z</forename><surname>Finklestein</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">97</biblScope>
			<biblScope unit="page" from="2998" to="3003" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b212">
	<analytic>
		<title level="a" type="main">Guidelines for the management of pediatric and adult tumor lysis syndrome: an evidence-based review</title>
		<author>
			<persName><forename type="first">B</forename><surname>Coiffier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Altman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C-H</forename><surname>Pui</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Younes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Cairo</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Oncol</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page" from="2767" to="2778" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b213">
	<analytic>
		<title level="a" type="main">Recommendations for the evaluation of risk and prophylaxis of tumour lysis syndrome (TLS) in adults and children with malignant diseases: an expert TLS panel consensus</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Cairo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Coiffier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Reiter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Younes</surname></persName>
		</author>
		<author>
			<persName><surname>Tls Expert</surname></persName>
		</author>
		<author>
			<persName><surname>Panel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Br J Haematol</title>
		<imprint>
			<biblScope unit="volume">149</biblScope>
			<biblScope unit="page" from="578" to="586" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b214">
	<analytic>
		<title level="a" type="main">The clinical management of tumour lysis syndrome in haematological malignancies</title>
		<author>
			<persName><forename type="first">A</forename><surname>Will</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Tholouli</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Br J Haematol</title>
		<imprint>
			<biblScope unit="volume">154</biblScope>
			<biblScope unit="page" from="3" to="13" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b215">
	<monogr>
		<title level="m" type="main">Nutritional support in acute renal failure. Handbook of nutrition and the kidney</title>
		<author>
			<persName><forename type="first">W</forename><surname>Druml</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2005">2005</date>
			<publisher>Lippincott Williams &amp; Wilkins</publisher>
			<biblScope unit="page" from="95" to="114" />
			<pubPlace>Philadelphia</pubPlace>
		</imprint>
	</monogr>
	<note>5th ed</note>
</biblStruct>

<biblStruct xml:id="b216">
	<analytic>
		<title level="a" type="main">Nutritional assessment and delivery in renal replacement therapy patients</title>
		<author>
			<persName><forename type="first">E</forename><surname>Fiaccadori</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Cremaschi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Regolisti</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Semin Dial</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="page" from="169" to="175" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b217">
	<analytic>
		<title level="a" type="main">ESPEN Guidelines on parenteral nutrition: adult renal failure</title>
		<author>
			<persName><forename type="first">N</forename><surname>Cano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Aparicio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Brunori</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Carrero</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Cianciaruso</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Fiaccadori</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Nutr</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="page" from="401" to="414" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b218">
	<analytic>
		<title level="a" type="main">Nutritional support in acute kidney injury</title>
		<author>
			<persName><forename type="first">E</forename><surname>Fiaccadori</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Parenti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Maggiore</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Nephrol</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="page" from="645" to="656" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b219">
	<analytic>
		<title level="a" type="main">High protein intake during continuous hemodiafiltration: impact on amino acids and nitrogen balance</title>
		<author>
			<persName><forename type="first">R</forename><surname>Bellomo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">K</forename><surname>Tan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Bhonagiri</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int J Artif Organs</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="page" from="261" to="268" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b220">
	<analytic>
		<title level="a" type="main">Copper, selenium, zinc, and thiamine balances during continuous venovenous hemodiafiltration in critically ill patients</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Berger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Shenkin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Revelly</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Clin Nutr</title>
		<imprint>
			<biblScope unit="volume">80</biblScope>
			<biblScope unit="page" from="410" to="416" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b221">
	<analytic>
		<title level="a" type="main">Long term risk of CKD in children surviving episodes of acute kidney injury in the intensive care unit: a prospective cohort study</title>
		<author>
			<persName><forename type="first">C</forename><surname>Mammen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Al</forename><surname>Abbas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Skippen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Kidney Dis</title>
		<imprint>
			<biblScope unit="volume">59</biblScope>
			<biblScope unit="page" from="523" to="530" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b222">
	<analytic>
		<title level="a" type="main">Risk of chronic dialysis and death following acute kidney injury</title>
		<author>
			<persName><forename type="first">R</forename><surname>Wald</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">R</forename><surname>Quinn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">K</forename><surname>Adhikari</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Med</title>
		<imprint>
			<biblScope unit="volume">125</biblScope>
			<biblScope unit="page" from="585" to="593" />
			<date type="published" when="2012">2012</date>
		</imprint>
		<respStmt>
			<orgName>University of Toronto Acute Kidney Injury Research Group</orgName>
		</respStmt>
	</monogr>
</biblStruct>

<biblStruct xml:id="b223">
	<analytic>
		<title level="a" type="main">Alnerta Kidney Disease Network. Association between AJI, recovery of renal function, and long-term outcomes after hospital discharge</title>
		<author>
			<persName><forename type="first">N</forename><surname>Pannu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>James</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Hemmelgarn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Klarenbach</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin J Am Soc Nephrol</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="194" to="202" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b224">
	<analytic>
		<title level="a" type="main">Nephrologists follow-up improves all-cause mortality of severe acute kidney injury survivors</title>
		<author>
			<persName><forename type="first">Z</forename><surname>Harel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Wald</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Bargman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Kidney Int</title>
		<imprint>
			<biblScope unit="volume">83</biblScope>
			<biblScope unit="page" from="901" to="908" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
